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Q U I L L  O N  S C A L P E L  This section
provides a medium through which Canadian 
surgeons can declare themselves, briefly and in­
formally, on the day-to-day affairs of surgery.
PUS BONUM ET LAUDABILE OR ANTIBIOTICS?
Semmelweiss and Lister changed surgical 
wards from putrid smelling, frightening areas 
to clean places with the pervading smell of 
carbolic acid. They also drastically reduced 
postoperative mortality due to surgical 
wound infections. The discoveries of Louis 
Pasteur changed operating room procedures 
from antiseptic to aseptic surgical tech­
niques, and this change led to a further re­
duction in the incidence of postoperative in­
fectious complications. It also had the effect 
of changing the commanding presence of the 
surgeon operating in his morning coat or 
evening dress into the surgeon working in 
the present gleaming operating room suites 
populated by shrouded mummies.
A second Listerian period started with the 
discovery of antibiotics. Their effectiveness 
in killing bacteria tempted the surgeons to 
use them indiscriminately as a panacea to 
prevent postoperative infections. In fact, 
there were some nonfacetious suggestions 
of reinstituting Lister’s spray loaded with 
antibiotics and using this in the operating 
rooms. Antibiotics were mixed into tooth­
paste and chewing gum, used for food pre­
servation and added to animal fodder until 
it was recognized, almost too late, that this 
leads to the emergence of highly resistant 
microorganisms. The over-reliance on anti­
biotics led to slips in well-established aseptic 
techniques in the operating rooms. The dan­
ger of indiscriminate use of antibiotic was 
recognized and newer, more rational ap­
proaches were recommended. The results of 
prospective studies on the use of prophylac­
tic antibiotics in surgery and the emerging 
recommendations are discussed in this issue 
by L. D. MacLean (page 243). Special areas 
of antibiotic prophylaxis became recognized: 
for example, antibiotic prophylaxis prior to 
instrumentation of the bacteriuric patient.
One area in which the value of antibiotic 
prophylaxis at the moment is not clearly 
established is the implantation of prostheses 
during clean surgical operations. Although 
some forms of antibiotic prophylaxis are 
practised by many surgeons, the lack of well- 
defined prospective studies leaves some 
questions. The appearance of infected pros­
thetic heart valves caused by Staphyloccoc- 
cus epidermidis, an unusual pathogen of low 
invasiveness, underlines the need for further 
studies.
The response of the host against invading 
microorganisms is probably the single most 
important factor in determining the post­
operative fate of injured tissues. No antibac­
terial agent can even approach the efficiency 
of the concerted antibacterial effect of host 
response. The role of these factors is dis­
cussed by J. L. Meakins (page 259). Mani­
pulation of these defence mechanisms in 
adaptation of the host to an allograft became 
everyday practice for transplant surgeons, 
who are highly skilled in navigating a sea of 
potential infections in the immunosuppressed 
host. In spite of our sophistication in man­
aging infections, the ultimate fate of a trans­
plant recipient is more dependent on the 
outcome of infections than on the adequate 
functioning of the transplanted organ. Al­
though the genetically determined absence 
of defence mechanisms is rather rare, the 
iatrogenic or acquired immunodeficiencies 
are becoming more common. The surgical 
management and rational antibiotic therapy 
in such patients is becoming the everyday 
concern of surgeons. Laboratory tests that 
can establish the degree of immunologic de­
ficiencies of a patient are at the moment 
difficult and lack accuracy. They are being 
developed rapidly and they will, in the not 
too distant future, become available to sur-
May 1975 THE CANADIAN JOURNAL OF SURGERY 211
geons who wish to predict the state of cel­
lular defences of their patients. When this 
time comes, the surgeon will resemble the 
careful general who will spy on all defence 
installations first, before attacking.
None of these developments will be satis­
factory if we neglect the improvement of the 
operating theatre. Our society is technolo­
gically capable of placing several thousand 
tons of hardware on the surface of the moon, 
and having two astronauts emerge from a 
spaceship to drive around and set up 
sophisticated scientific equipment without 
spreading a single live microorganism. We 
have to find ways of acquiring the means 
to apply some of these technologic sophis­
tications to provide an operating room en­
vironment that will diminish the risk of ex­
posing the wounds to bacteria. Hospitals do 
not have the budgets that can approach the 
range of space spectacles, but some of the 
available budgets can be better spent. To 
convince those who'control these budgets, 
we have to acquire the vocabulary and 
methodology of a cost accountant and start 
prospective studies to prove that the money 
spent on improvement of operating rooms 
would reduce hospital stay and postoperative 
costs.
St e p h e n  I. V as, MD, PhD, FRCP[C] 
Microbiologist-in-chief,
Department of Microbiology and Immunology, 
Royal Victoria Hospital and McGill University, 
Montreal, Que.
AMPUTATION IN ISCHEMIC FOOT DISEASE
The paper by Hunter in this issue of the 
Journal (page 273) reports the experience 
of the Toronto teaching hospitals with 
limited amputation of the foot as an ac­
ceptable solution for patients with gangrene 
of the foot complicated by diabetes or 
arteriosclerosis. In all of the patients studied 
foot pulses were absent.
Foot problems in the elderly have 
become prevalent and debilitating. Suc­
cessful management of this problem is 
not measured by length of hospital stay, nor 
is it generally amenable to statistical criteria, 
such as are frequently presented in hospital 
statistics. The loss of a limb in the elderly 
has results that are measured in terms of 
social and family disruption, employability, 
and limited activity, and it is the avoidance 
of these effects that characterizes a success­
ful outcome. Limb amputation in the middle- 
aged and younger individuals, although a 
major disability, allows some hope for suc­
cessful rehabilitation. Amputation is a dis­
ablement of such magnitude that any effort 
that can possibly save an extremity useful for 
walking is justified.
The limb is jeopardized by a superim­
posed infection that usually begins at the 
edge of toenails, in the web spaces or as 
plantar surface ulcers —  infections made 
more virulent by the presence of diabetes or 
arteriosclerosis, or both. Hunter makes the
point that in the Toronto experience the 
diabetics were no different in their response 
to foot infections and subsequent treatment 
from nondiabetics, and that therefore 
diabetes itself should not be considered a 
major problem. Hunter’s paper focuses at­
tention on the role of impaired blood supply 
as the condition that is critical in the body’s 
inability to respond adequately to the infec­
tion and heal the surgical wound, so the 
support of blood supply becomes a crucial 
factor in management. Hunter brings into 
focus the surgeon’s obligation to examine 
the blood supply carefully and to determine 
appropriately the nature and cause of im­
pairment, including adequate arteriography 
when indicated and peripheral vascular re­
pair whenever possible.
The author emphasizes operations in the 
region of the foot. In a retrospective study, 
he is not permitted to view at first hand the 
nature of the infection, its treatment and 
subsequent wound management at the am­
putation site, and the possible impact that 
appropriate wound management may have 
had on the successful outcome. Surgical 
wounds of this nature are always contamin­
ated to some degree, and careful treatment 
of the wound can exclude the postoperative 
infection that necessitates a higher amputa­
tion. The results reported are related more 
to the pulses than to the nature of the
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wounds, and most of the comparative results 
from other series reported in this paper are 
related to the presence or absence of pulses. 
Hunter has clearly demonstrated that in 
some feet, even in the absence of distal 
pulses, there are collaterals with blood sup­
ply that is adequate for wound healing if the 
management is meticulous, since the To­
ronto series is composed solely of patients 
with peripheral vascular disease and no 
palpable foot pulses.
The tables in this paper present statistical 
comparisons between several reported series 
of operations. These tables permit one to 
conclude than an operation should be tail­
ored to the condition of the foot, and when 
this is done a moderate degree of salvage 
may be obtained. The tables do not demon­
strate the superiority of one procedure over 
another, because the groups subjected to 
the various procedures were not identical 
in their initial presentation.
C. B a rber  M u e l l e r
Bibliography
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THE WORD, “SURGERY”
Words are slippery creatures that are, in the 
natural course of events, subject to a process of 
mutation. And these mutations may be for good 
or ill. The very word ‘‘surgery’’ is an example of 
the way word usage is often slipshod, as Ernst in 
a recent editorial notes (Surg Gynecol Obstet 140: 
608, 1975). Some will ask, ‘‘Does abuse of such a 
word matter?”, but a majority, one hopes, will 
object to abuse of the word, and for pragmatic 
reasons. Ernst objects to expressions such as 
“doing surgery on a patient” for two reasons: 
first, such expressions demean the discipline, be­
cause “surgery" denotes work that encompasses 
much more than technical expertise; and, second, 
such expressions fail to convey to colleagues that 
“surgery is much more than cutting". Ernst’s 
editorial, framed and hung, might appropriately 
be seen in many operating rooms—and even 
some editorial offices.
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VILLOUS ADENOMA OF THE CECUM
SURENDAR K. KILAM, MB, BS, FRCS[C],* LAMBROSE B. COSTOPOULOS, M D t and 
WALTER W. YAKIMETS, MD, FRCS[C], FACSt
Summary: Villous adenoma of the cecum de­
veloped in a 49-year-old man; the diagnosis was 
confirmed at operation. The pathologic and 
radiologic features of villous tumour in this 
location differ from those of tumours situated in 
the sigmoid colon and rectum. Signs and symp­
toms are vague; bleeding per rectum may not 
occur. Right hemicolectomy is recommended 
because of the high malignant potential of this 
tumour.
Resume: Nous presentons ici le cas d'un ade- 
nome villeux du caecum qui s'est developpe 
chez un homme de 49 ans. L'operation a confir­
ms le diagnostic. Les caracteres pathologiques 
et radiologiques de cette tumeur different des 
tumeurs localisees dans le colon sigmoide et le 
rectum. Les signes et symptomes restent va- 
gues: I'hemorragie rectale n'est pas obligatoire. 
Nous conseillons une hemicolectomie, en raison 
du potentiel eleve de malignite de la tumeur vil- 
leuse du caecum.
V il l o u s  adenomas are common in the rec­
tum and sigmoid colon but rare in the 
cecum. In reviewing papillary tumours of the 
colon and rectum, Bacon, Lowell and 
Trimpi1 and Swinton, Meissner and Soland2 
each reported one tumour in the transverse 
colon, and Fisher and Castro3 found one in 
the ascending colon. In the Ochsner Clinic 
series,4 in 163 cases only two villous adeno­
mas arose in the cecum and one in the ap­
pendix.
Villous adenomas are usually sessile, 
consisting of projecting mucosal villi piled 
on one another; grossly, the clefts between 
the villi give them an irregular appearance. 
The mode of presentation and the clinical 
features vary, depending on the site and 
size of the tumour. Sigmoid tumours are oc-
*Department of surgery, Memorial University of 
Newfoundland, St. John’s, Nfld.
t Department of radiology, University of Alberta 
Hospital, Edmonton, Alta.
t Department of surgery, University of Alberta 
Hospital.
Reprint requests to: Dr. S. K. Kilam, Department 
of surgery, Memorial University of Newfound­
land, St. John’s, Nfld. A 1C 5S7.
casionally associated with diarrhea and fluid 
and electrolyte imbalances, as a result of 
the large losses of electrolyte-rich colonic 
mucus,5 but such symptoms have not been 
reported in cases of villous adenomas in the 
cecum. Radiologic appearances are usually 
typical; they are best seen in the postevacua­
tion film or by double-contrast studies.
The clinical and radiologic features of 
villous adenomas of the cecum are illus­
trated in the following case report.
C ase  R e p o r t
A 49-year-old man had a history of crampy 
right lower quadrant pain of 1 year’s duration. 
The pain was associated with headache, flush­
ing of the face and sweating; usually it started 
2 hours after a meal. In between these cramps, 
he had a persistent dull ache in the same area. 
The frequency of bowel movements had in­
creased from one to two each day. For 2 
months before admission, the patient had been 
taking Maalox, which relieved the right lower 
quadrant pain. He also noted that ingestion of 
beer caused increased pain and the appearance 
of bright red blood in the stools.
The main physical findings were as follows: 
His height was 160 cm and his weight, 78 kg. 
He was in no acute distress, but the right lower 
quadrant of the abdomen was tender on pal­
pation. Other findings, including those on 
rectal and sigmoidoscopic examination, were 
normal.
Laboratory investigation revealed a normal 
complete blood count, erythrocyte sedimenta­
tion rate, blood urea nitrogen concentration 
and serum electrolyte concentrations. The re­
sult of the screening test for carcinoid tumour 
was negative. Occult blood was detected in the 
stools. Fluoroscopy and air-contrast studies 
of the barium-filled colon showed th, t there 
was no reflux of barium into the terminal ile­
um, but a large, lobulated filling defect (Fig. 
1) (dimensions, 4 cm x 4 cm) was seen in 
the cecum, with the base of the lesion in its 
lateral wall; the filling defect was persistent and 
apparent after evacuation of the barium and 
clearance of air contrast. The appendix was 
filled with barium and was unremarkable. The 
suggested radiologic diagnosis of this filling 
defect was a polypoid adenocarcinoma.
An exploratory laparotomy was performed
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through a right paramedian incision. A  soft 
polypoid mass was palpated in the cecum. 
The remainder of the gastrointestinal tract and 
the liver felt normal. A  cecotomy was per­
formed because the cecal lesion did not feel 
like a carcinoma and because the tumour was 
broad-based. Frozen-section biopsy of a speci­
men of tumour tissue revealed evidence of a 
villous adenoma. A  limited right hemicolec­
tomy was performed after closure of the ce­
cotomy. Microscopic examination of the tissue 
showed histologic features of a villous papillo­
ma with no evidence of malignancy. Sections 
of regional lymph nodes were negative.
D iscussion
The majority of villous adenomas are 
found in the rectosigmoid region although 
they have been noted in the duodenum, 
stomach and gallbladder. In one series of 
1032 cases of villous adenomas, only 1.3% 
(13) of adenomas arose in the cecum.6 In 
another, of more than 50 villous adenomas, 
83 % were either palpable or visible through
Fig. 1.—Demonstration of villous adenoma of 
cecum as large filling defect by fluoroscopy with 
air contrast.
the sigmoidoscope; and although 17% were 
located proximal to the sigmoid colon none 
arose from the right side of the colon.7
The radiologic features of villous tumours 
are often sufficiently typical to suggest the 
correct diagnosis. Double-contrast examin­
ation of the colon usually shows a bulky 
intraluminal mass with irregular contour 
(Fig. 2). After evacuation, the villous tumour 
changes size and configuration and shows a 
reticulated pattern produced by barium 
caught within the collapsed mass. The 
colonic segment harbouring a villous ade­
noma shows preserved haustral markings, 
good distensibility and a bubbly mucosal 
pattern.
Differentiation between benign and malig­
nant tumours of the cecum is not always 
possible before operation. Striking changes 
on follow-up examination such as fixation, 
luminal narrowing, destruction of the adja­
cent haustral markings and ulceration of 
the mass may suggest the probability of 
malignant degeneration. When the bowel 
wall is involved in a superficial spreading 
manner, in appearance the lesion may 
be confused with retained stool; the diag­
nosis is established by proper colonic pre-
Fig. 2.—Irregular contour of bulky intraluminal 
mass revealed by double-contrast examination.
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paration and further examination. Intra­
mural soft polypoid lesions (e.g. lipoma) 
should not be confused with villous tumours.
The incidence of malignancy and of as­
sociated colonic lesions is high in cases of 
villous adenoma of the cecum.8' 9 Olson 
and Davis10 found a clear relationship be­
tween the size of the lesion and the inci­
dence of malignancy: in lesions smaller than 
2 cm in diameter, the incidence of malignan­
cy was 24.4%  and in lesions larger than 5 
cm in diameter the incidence of malignancy 
was 80% .
Most discussions regarding the therapy of 
villous tumours relate to the rectosigmoid 
lesions and have little application to ade­
nomas situated in the cecum. For villous 
adenomas in this region, right hemicolectomy 
is recommended because of the high 
malignant potential of these tumours.
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IMPEDANCE PHLEBOGRAPHY:
ACCURACY OF DIAGNOSIS IN DEEP VEIN THROMBOSIS*
JACQUES E. NADEAU, MD, ROBERT DEMERS, PhD, BERNARD SKINNER, MD, 
FRCP[C] and LLOYD D. MacLEAN, MD, FRCSfC]
Summary: In an evaluation of the diagnostic 
accuracy of impedance phlebography for the 
diagnosis of deep vein thrombosis, 51 limbs in 
32 patients were examined simultaneously by 
impedance phlebography and by venography. 
The impedance diagnosis was accurate in 47 
limbs, erroneous in 2 and inconclusive in 2; the 
overall accuracy was 92%. Simultaneous clinical 
diagnosis yielded an accuracy of 53%.
The method requires full cooperation by the 
patient and meticulous attention to the details 
of the test by the physician or technician per­
forming the examination.
Resume: Pour nous permettre d'evaluer le degre 
de precision de la phlebographie sous impe­
dance dans le diagnostic de thrombose des vei- 
nes profondes, nous avons examine 51 membres 
chez 32 malades, simultanement par phlebogra­
phie sous impedance et par phlebographie sim­
ple. Le premier type d'examen s'est revele exact 
dans 47 membres, errorie dans 2 autres et n’a 
pas permis de conclure dans les 2 derniers cas. 
Le degre de precision atteignait 92%. Un dia­
gnostic clinique simultane n'a ete exact que 
dans 53% des cas.
Pour etre efficace, cette methode exige une 
cooperation etroite du malade et, de la part du 
medecin ou du technicien qui pratique I'examen, 
une attention meticuleuse des details.
I m p e d a n c e  phlebography, as described in 
1970 by Mullick, Wheeler and Songster,1 
initially promised to be a useful method of 
making the early diagnosis of deep vein 
thrombosis. Together with suitable prophy­
lactic measures, it also promised to aid in 
the prevention of pulmonary embolism. 
Results of more recent studies, however, 
contradicted those of the initial work.2'4
Wheeler and his associates obtained diag­
nostic accuracy of 97% , using venography3
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as the absolute reference, and Gazzaniga, 
cited by Wheeler,5 achieved an accuracy of 
100% in a group of normal volunteers. Stu­
dying the limb in a different position, so that 
the limb was under tension rather than re­
laxed, Dmochowski, Adams and Couch4 
reported an overall accuracy of 53% ; they 
recorded false-positive results in 47% but 
still considered the method useful because of 
the low incidence (23%) of false-negative 
results. In contrast, Steer’s group2 found 
an incidence of false-negative results of 39 % 
but no false-positive results; moreover, 
20% of the recordings were nondiagnostic 
and 20% of the patients seen were not tech­
nically suitable for the test. Finally, Deu- 
vaert, Dmochowski and Couch3 studying 
the leg in different positions, as well as that 
described by Wheeler and that by Dmo­
chowski, obtained an overall accuracy of 
68% with 38% false-positive and 16% 
negative results.
This report summarizes our own attempt 
to evaluate the method and to determine the 
possible causes for the discrepancy in re­
sults by others reporting on the technique. 
In particular, we have examined artifacts in 
the impedance wave forms caused by dif­
ferent respiratory maneuvers.
M a t er ia l  a n d  M et h o d s
We did not specifically select the patients 
for this study. Patients were referred usually 
because of the clinical possibility of venous 
thrombosis.
Calf impedance was measured with a bat­
tery-operated impedance meter (Codman 
& Shurtleff, model IPG-100) originally de­
scribed by Mullick, Wheeler and Songster1 
and by Wheeler and Mullick.6 A constant 
current of less than 1 mA is applied to a 
pair of circumferential electrodes. The cir­
cumferential electrodes were applied 10 cm 
apart in the widest part of the calf, and 
voltage proportional to the calf impedance 
is detected by a second inner electrode pair. 
The output of the meter is a measure of the 
percentage change from the baseline im-
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pedance; a calibrated, 0.2% impedance step 
change is built in for adjustment of recorder 
sensitivity.
Respiratory movements, consisting of a 
deep thoracic inspiration and a passive ex­
piration, were monitored by a simple pneu- 
matometer constructed of a segment of cor­
rugated tubing, which was placed around 
the chest and connected to a pressure trans­
ducer. Both the impedance and the respira­
tory transducer signals were registered on a 
two-channel direct-writing recorder.
Adequate relaxation of patients before 
any recordings were made was important. All 
patients were studied in the recumbent po­
sition; the leg to be studied was externally 
rotated and flexed between 30 and 45° 
at the hip and the knee, and was supported 
on a small pillow for maximal comfort and 
relaxation.
In all patients, the limb thought to be 
normal was studied first. After several re­
producible recordings of adequate technical 
quality had been obtained for the normal 
limb, the limb thought to be affected by 
venous thrombosis was then studied. This 
approach ensured the best possible tech­
nique for each patient, with reference to 
position of the limb, respiratory movement 
and relaxation. Interpretation was made ac­
cording to the maximum impedance varia­
tion, and for this series Wheeler’s criteria 
were adopted. Patency of the venous system 
was signified by changes in baseline impe­
dance exceeding 0.2%. Occlusion was in­
dicated by variations of less than 0.15% 
whereas values in between were considered 
of uncertain diagnostic accuracy or border­
line. Venograms were performed within 48 
hours of the impedance recordings to veri­
fy findings with respect to both clinical diag­
nosis and impedance phlebography.
R esults
In all, 51 limbs in 32 patients were stu­
died at intervals of from 4 hours to 6 months 
after the onset of symptoms. In 28 instances 
thrombophlebitis had been diagnosed or 
suspected, and in 10 other instances pul­
monary embolism had been diagnosed or 
suspected. Vena caval ligation had been 
performed in one patient in whom both legs 
were studied. In the other 11 instances the 
limbs studied were believed to be normal.
The impedance diagnosis was confirmed 
in 47 limbs by venography (accuracy, 92%): 
for 2 other limbs (4%) the impedance values 
were erroneous, and for 2 others (4%) the 
findings were inconclusive (Fig. 1).
Fig. 1 also indicates that impedance phle­
bography usually gave distinctly positive or 
negative findings, with a small borderline 
group. Moreover, the accuracy of the meth­
od was unchanged in a survey of all eight 
patients in whom the venogram revealed 
abundant collateral circulation.
The clinical diagnosis was correct in 53% 
of cases. In five cases false-positive results 
were obtained and in four, false-negative 
results; in all of these cases impedance phle­
bography yielded an accurate diagnosis.
Venography revealed the distribution of 
thrombosis along the deep venous system; 
there was widespread disease from the tibi­
alis vessels to the vena cava (Table I).
Three case histories illustrate the accuracy 
of the method in different clinical situations.
Case 1.— A 50-year-old woman with dia­
betes had a 7-year history of bilateral calf ten­
derness and ankle and calf swelling with de­
pendency. She had had deep vein thrombo­
phlebitis of both legs 4 years before admission. 
A clinical diagnosis of bilateral postphlebitis 
limb disease was made. Her symptoms were 
alleviated by elevation and use of elastic stock­
ings. Impedance phlebography yielded an im­
pedance variation of 0.42% in the right leg
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Fig. 1.—Results of impedance phlebography in 
51 limbs.
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and of 0.46% in the left leg; bilateral veno­
graphy showed that the deep veins were 
entirely normal, with no evidence of old or 
recent phlebitis of the venous system (Fig. 2).
In this case impedance phlebography had 
good reliability in a patient whose legs were 
edematous and painful owing to a lesion other 
than deep venous occlusion.
Case 2 .—A 77-year-old woman sustained a 
pathologic fracture of the left femur secondary 
to a metastatic breast lesion. Internal fixation 
was performed and a course of radiation thera­
py was given. Massive painless edema of the 
left leg from the upper thigh to the foot de­
veloped 1 week after the completion of radia­
tion therapy. Impedance phlebography yielded 
an impedance variation of 0.12%. A veno­
gram revealed the presence of clot in the thigh 
and calf, and complete occlusion of the deep 
venous system at the common femoral vein 
(Fig. 3). The patient was treated with intra­
venous heparin and over the following week 
the swelling resolved completely.
Fig. 2.—Impedance phlebogram, respiratory 
curve and venograms for left leg (case 1). Veno­
gram shows that deep veins of leg are free of 
thrombosis, and impedance change is well within 
normal range. (Respiratory curve and venograms 
are aligned with time on horizontal axis; respira­
tory curve does not quantitate respiratory man­
euver.)
Case 3 .—A 77-year-old woman with long­
standing, chronic, renal failure was admitted 
for investigation of a swollen and tender left 
calf; the presumptive diagnosis was of deep 
thrombophlebitis. On admission the right leg 
was entirely normal. Bilateral impedance phle­
bography yielded an impedance variation of 
0.05% for both the right and left legs. Veno­
graphy demonstrated complete occlusion of 
the left deep venous system and on the right, 
occlusion of the right superficial femoral vein 
with recanalization in the mid-thigh and oc­
clusion of the right common femoral vein at 
the inguinal ligament level (Fig. 4).
Discussion
Our results support the value of impe­
dance phlebography reported by Mullick, 
Wheeler and Songster,1 and by Wheeler.5’ 7 
Our findings included a few “borderline” re­
sults (0.16 to 0.24%) (Fig. 1), in contrast 
to the findings of Steer and associates,2 who 
reported a 20% incidence of such results. 
It is also possible that the “borderline” area 
is narrower than that suggested by Wheeler 
and his colleagues.5
The discrepancy in results among re­
porters is probably explained by differences 
in technique. In the present study three 
aspects were emphasized: (a) the position 
of the limb, (b) the respiratory maneuver, 
and (c) the reproducibility obtained before 
the test and the precise interpretation of the 
recordings.
The position of the limb at the time of
TABLE I.—Localization of Occlusions or 
T hrombi by Venography
Site (vein) No. of patients
Vena cava............................... 2
Common iliac.......................... 4
Common iliac and external 
iliac......................................... 1
External iliac and common 
femoral.................................... 4
Common and superficial 
femoral.................................... 1
Deep femoral.......................... 1
Superficial femoral.................. 2
Superficial femoral and 
popliteal.................................. 3
Superficial femoral, popliteal 
and trifurcation...................... 1
Trifurcation............................ 3
Entire deep venous system (ex­
ternal iliac to tibialis).............. 2
Total....................................... 24
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the study is important; an ideal position will 
prevent undue compression on the venous 
system from the surrounding tissue that can 
produce false-positive results. This ideal 
position is found by first testing the clinic­
ally normal limb; otherwise, bias in the tech­
nician’s mind leads him to obtain a position 
and an adequate respiratory maneuver that 
will give a normal tracing. This position, 
though varying slightly from patient to pa­
tient, has been within 30 to 45° of flexion 
of hip and knee with external rotation in all 
cases. It is comparable to the one proposed 
by Wheeler.5 After reviewing Dmochowski’s 
results4, which did not support the accuracy 
of the method and which were obtained with 
a different position, Wheeler used both posi­
tions in the same group of patients and 
showed that the accuracy of the method was 
dependent on the position.5
The respiratory maneuver leading to the 
observed maximal impedance variation de­
mands even greater attention to technique. 
Lack of relaxation of the patient or undue 
straining during the test can produce false­
positive results. Forceful expiration will 
cause additional intra-abdominal pressure
Fig. 3.—Impedance phlebogram, respiratory 
curve and venograms of left leg (case 2). Flattened 
impedance curve corresponds on venogram (from 
left to right) to numerous filling defects in calf 
veins and near absence of venous system in thigh.
with either delay of the return to baseline or 
a new peak in the impedance deflection be­
fore return to baseline, leading to confusion 
in the calculation of the “true” deflection. 
For similar reasons, a Valsalva maneuver, in­
stead of the deep and sustained inspiration, 
will cause a greater obstruction to venous 
outflow and, therefore, false-negative inter­
pretations.
To obtain a reproducible recording we 
have found it necessary to train the patient 
to perform a maneuver properly. In order to 
recognize an optimal respiratory maneuver 
and to estimate more accurately the maxi­
mum impedance variation, a pneumatometer 
is useful. We found that its deflection per­
mitted a better correlation of changes ob­
served in the impedance recording with the 
pattern of the respiratory curve; it usually 
permits one to differentiate artifactual de­
flection caused by movement rather than 
inspiration, and precise knowledge of the
Fig. 4.— Impedance phlebogram, respiratory 
curve and venograms of right leg (case 3). Filling 
defects along superficial and common femoral 
veins with collateral circulation, and positive im­
pedance test performed during respiratory man­
euver.
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onset, true peak and depth of inspiration—  
and therefore a more accurate measurement 
of the impedance deflection produced.
Su m m a r y  a n d  C o n c l u s io n s
The technique of impedance phlebogra­
phy we have described has been useful in 
detecting thrombi in large veins from the 
tibialis vessels to the vena cava. The method 
is noninvasive and appears equally ap­
plicable to the detection of old or recently 
formed thrombi. Its main limitation is the 
need for good cooperation by the patient 
and for time-consuming attention to detail. 
The test is not suited to patients who are 
agitated, confused, unconscious, or severely 
dyspneic, or to patients with limbs in plaster 
or in traction. Nevertheless, many patients 
remain accessible to study, and impedance 
phlebography should be explored further as 
a diagnostic measure in symptomatic as well 
as asymptomatic patients at risk. The tech­
nique does detect thrombi proximal to the 
inguinal ligament, which was the site of 
thrombosis in many of the patients herein 
reported.
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CORRELATION BETWEEN HEMODYNAMIC CHANGES AND THE 
PRESENCE, SIZE, AND SITE OF MYOCARDIAL INFARCTION*
C. EDWIN KINLEY, MD, FRCS[C], ALLAN E. MARBLE, MEng, PEng,
AT T AN  S. MacDONALD, MD, FRCS[C] and VICTORIA L. MASLAND, BSc
Summary: Values for eight measured and cal­
culated hemodynamic variables were recorded 
in 12 dogs before and after experimental an­
terior myocardial infarction. Changes were 
noted in stroke work and stroke power only; 
the changes in stroke work and stroke power 
were closely correlated with the presence of 
the infarct, whereas the changes in the other six 
dynamic variables were unpredictable and un­
correlated. The degree of correlation between 
the stroke work and power, and the size and 
site of the infarction, however, suggested that 
none of the eight variables would be an ade­
quate indicator of all three characteristics of 
the infarction.
Resume: Chez 12 chiens ayant subi un infarctus 
anterieur du myocarde, nous avons enregistre 
les valeurs des huit variables hemodynamiques, 
tant qu'avant qu'apres I'infarctus experimental. 
Nous n'avons note de modifications que dans 
le travail systolique et la puissance de la con- 
tractilite ventriculaire. Ces changements reve- 
laient une correlation etroite avec la presence 
de I'infarctus. D'autre part, les changements ob­
serves dans les six autres variables de I'hemo- 
dynamique etaient imprevisibles et denues de 
correlation avec I'accident du myocarde. Par 
contre, le degre de la correlation existant entre 
le travail systolique et la puissance de la con- 
tractilite ventriculaire d'une part, et, d'autre part, 
la dimension et le siege de I'infarctus permet de 
croire qu'aucune des huit variables puisse cons- 
tituer un indicateur valable des trois caracteris- 
tiques de I'infarctus du myocarde.
*From the departments of surgery and anatomy, 
faculty o f medicine, Dalhousie University, and the 
department of electrical engineering, Nova Scotia 
Technical College, Halifax, NS.
Supported by the National Research Council of 
Canada grant A-8007.
Reprint requests to: Professor A. E. Marble, 
Department of surgery, 13K - Tupper Building, 
Dalhousie University, Halifax, NS B3H 4H7.
T h e r e  are several methods for the detection 
of the presence, site, size, and associated 
asynergy of myocardial infarction.1 How­
ever, none of the methods used independent­
ly is adequate for a proper diagnosis of all 
aspects of infarction. Whereas a method 
may be quite reliable in predicting the pre­
sence of an infarct, it may convey little in­
formation regarding its size, site, and as­
sociated asynergy. There are three main 
approaches to this problem: indirect, quali­
tative and quantitative. Most methods pro­
vide either an indirect assessment of the 
presence of the infarction (i.e. electrocar­
diogram, enzymes, systolic time intervals, 
or maximal velocity of contraction), or quali­
tative information regarding its site or 
asynergy (i.e. ventriculography, apexcardio- 
graphy and echocardiography). Also of in­
terest is the quantitative assessment of the 
performance of the heart, for the patient’s 
survival depends on the simultaneous main­
tenance of an adequate cardiac output and 
an adequate aortic pressure, and consequent­
ly an appropriate supply of oxygen to the 
tissues. A combination of the information 
obtained from the three approaches could 
provide a better means of diagnosing and 
assessing the treatment of myocardial infarc­
tion.
The quantitative approach to assessment 
has been somewhat overshadowed by the 
indirect and qualitative approaches. This has 
resulted from the difficulty in continuously 
measuring cardiac output in the intact pa­
tient, and it has meant that there is little in­
formation on the correlation between 
hemodynamic changes accompanying myo­
cardial infarction and the presence, size, and 
site of the infarct. This problem of meas­
urement has been overcome by the recent 
development of the catheter type of elec­
tromagnetic flow probe.2 It is now possible 
to measure all hemodynamic variables as­
sociated with the heart accurately and 
safely.
The purpose of this paper is to present 
results from a controlled study on dogs of
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the correlations between alterations in the 
state of the myocardium and the resultant 
hemodynamic changes. The main objective 
of the study was to determine which hemo­
dynamic parameters best reflect the change 
in the state of the myocardium.
M e t h o d s
Twelve mongrel dogs (weight range, 20 
to 32 kg) were anesthetized with sodium 
thiopental (1 ml/kg body weight) and a 
uniform dose of succinylcholine (40 mg/ml). 
Ventilation was maintained with a Bird 
respirator connected to a cuffed endotra­
cheal tube. After induction of anesthesia a 
Teflon catheter (USCI no. 7) was advanced 
in the femoral artery to a point near the 
aortic arch for the recording of ascending 
aortic pressure (Hewlett Packard 7858A 
recorder with a Hewlett Packard 1280B 
transducer and a Hewlett Packard 8801A 
preamplifier). Thoracotomy was then per­
formed through an incision in the fourth 
interspace anteriorly. The ascending aorta 
was exposed, and a Statham electromagnetic 
flow probe (internal diameter, usually 
18 mm) was attached for measurement of 
the blood flow rate in the ascending aorta; 
this probe was used in conjunction with a 
Statham SP2001 nonocclusive, zero blood- 
flow flowmeter. Left ventricular pressure 
was obtained by means of a no. 7F Teflon 
catheter advanced through the left atrial 
appendage into the ventricle via the mitral 
valve; the derivative of left ventricular pres­
sure was obtained continuously (Hewlett 
Packard derivative computer). Heart rate 
and electrocardiogram (lead II) were also 
recorded continuously (Hewlett Packard 
bioelectric amplifier 8811A and Hewlett 
Packard 7858A eight-channel recorder). 
Control recordings of the variables were then 
obtained for all animals prior to infarction.
Infarction was induced by ligating the an­
terior descending artery just distal to the 
main septal artery. Continuous recordings 
of all variables were then taken for 30 min­
utes after creation of the infarct. When these 
measurements had been completed, the cir­
cumflex artery was injected with Micro- 
paque (Damancy & Co. Ltd., Slough, Eng­
land) at a pressure not exceeding 150 mm 
Hg. The heart was then removed, cooled
and fixed in formalin for 24 hours. Each 
heart was weighed and the net weight ob­
tained by subtracting the weight of the 
Micropaque injected. The fixed specimens 
were sliced from base to apex in 2-mm sec­
tions and contact angiograms made.3 The 
cross-sectional area of the left ventricular 
myocardium (including the septum), as well 
as the area of the infarct, was calculated for 
each slice. This technique of specimen 
preparation makes it possible to distinguish 
the infarcted myocardium from the nonin- 
farcted myocardium (Fig. 1). The areas, 
and consequently the volumes, of infarcted 
myocardium and overall left ventricular 
myocardium were established by superim­
posing a transparent grid of 0.25-cm (0.1- 
in) squares over each slice.
Stroke volume was calculated by dividing 
cardiac output by heart rate. Stroke power 
(the rate at which the heart is performing 
external work) was determined by multiply­
ing the mean ascending aortic pressure dur­
ing systole by cardiac output.4- 5 Mean 
aortic pressure during systole was calcu­
lated by using the approach suggested by 
Walker and colleagues.6 Stroke work was 
calculated by dividing stroke power by 
heart rate. Total peripheral resistance was 
determined by dividing mean ascending 
aorta pressure by cardiac output.
R e s u l t s
These studies illustrate the alteration in 
hemodynamics that accompanies anterior in-
Fig- 1 .—Typical slice of infarcted canine heart 
from which area and volume calculations were 
made. (Experiment no. 193; other data for this 
dog are given in Tables I and II.)
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farction of 35 to 45 % of the left ventricular 
myocardium. Tables I and II present data 
relating to the hemodynamic parameters, 
before and after infarction.
A statistical analysis of the percentage 
changes in cardiovascular dynamics accom­
panying infarction is shown in Table III. 
The correlation coefficients relating infarct 
size to percentage changes in the two most 
consistent changes (stroke power and stroke 
work) were 0.22 and 0.45, respectively 
(Fig. 2). Fig. 3 shows the site of the infarc­
tion relative to the apex and base of the 
heart.
D iscussion
The cardiovascular variables we studied 
are not the only dynamic variables that have 
been studied in the assessment of myocar­
dial infarction. Central venous pressure is 
sometimes used to indicate left ventricular 
filling pressure but it is not a reliable index 
because of the possibility of associated pul-
TABLE I.—Preinfarct Values of M easured and Calculated H emodynamics* for Individual D ogs 
and M ean and Standard Deviation Values for all 12 Dogs
Experiment
no.
Weight
{kg)
A P
(mm Hg) CO(,l/min) HR{beats/min) S V{ml) SP(watts)
SIP
(joules x
i o - 3)
TPR
(mm
Hg/ml ■ min)
171 30 120 1.68 140 12.0 0.46 3.27 0.075173 24 146 2.19 188 11.7 0.73 3.88 0.071177 26 133 2.24 136 16.4 0.68 5.00 0.060178 26 146 2.97 150 20.0 0.99 6.60 0.050179 32 93 3.18 188 17.0 0.68 3.60 0.030180 27 84 2.86 144 19.9 0.55 3.80 0.030182 25 160 1.50 176 8.5 0.54 3.06 0.108193 22 157 2.10 167 12.6 0.75 4.50 0.075194 22 125 2.25 131 17.2 0.64 4.73 0.055195 22 130 2.50 150 16.6 0.74 4.95 0.052186 20 136 2.60 136 19.1 0.81 5.95 0.052198 20 146 2.75 150 18.3 0.92 6.10 0.053
Mean 24.7 131 2.40 154.7 15.8 0.71 4.62 0.059
SD ±  3.8 ±  23.4 ±0.50 ±  20.2 ±  3.7 ±0.15 ±1.15 ±0.020
* Abbreviations: AP, mean ascending aorta pressure during systole; CO, cardiac output; HR, heart rate; SV, stroke volume; SW, stroke work; and TPR, total peripheral resistance.
TABLE II.—P ostinfarct Values* of M easured and Calculated Cardiovascular Dynamics) for Individual Dogs with M ean and Standard Deviation Values for all 12 D ogs
Experiment
no.
Weight
(kg)
A P
(mm Hg)
CO
(l/min)
HR
(beats/min)
S F
(ml)
SP
(watts)
SIP
(joules x 
10~3)
TPR
(mm
Hg/ml ■ min)
171 30 120 1.56 136 11.4 0.43 3.16 0.080173 24 135 2.26 187 12.0 0.70 3.74 0.059177 26 133 1.98 150 13.2 0.60 4.00 0.070178 26 146 2.65 167 15.9 0.89 5.30 0.056179 32 90 2.90 188 15.5 0.60 3.20 0.031180 27 86 2.52 144 17.3 0.50 3.48 0.034182 25 144 1.57 167 9.4 0.52 3.11 0.092193 22 157 1.70 176 9.7 0.61 3.46 0.092194 22 118 2.00 116 17.2 0.54 4.65 0.059195 22 115 2.20 140 15.7 0.58 4.15 0.052196 20 136 2.50 131 19.1 0.78 5.95 0.054198 20 137 2.65 150 17.6 0.83 5.55 0.052
Mean 24.7 126.4 2.21 154.3 14.5 0.63 4.15 0.061
SD ±  3.8 ±  21.6 ±0.45 ±  22.8 ±  3.3 ±0.14 ±0.99 ±0.02
*Values are for data measured approximately 30 minutes postinfarct. (Abbreviations as in Table I.
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TABLE III. Statistical Analysis of H emodynamic P ercentage Changes in  Anterior M yocardial
Infarction* in 12 Dogs
Hemodynamic Mean Range
Standard
deviation
Ascending aorta pressure........................ -  6.8
-  7.0
-  0.4
-  7.1 
-10 .7  
-10 .4  
+  5.9
-  1.6
-11 .5  -> +  2.4 
-12 .0  -> +  11.9 
-11 .4  — +  11.1 
-19 .8  -> +  10.6
-  4.1 -» -  21.5
-  0.1 -> -  23.2 
-14 .0  -> +  22.7 
-16 .5  — +  13.3
±  7.4Cardiac output...........................
Heart rate...........................
Stroke volume..................
Stroke power......................
Stroke work......................
Total peripheral resistance........................... ±11.2
±11.6Derivative of left ventricular pressure)..........
* Infarct size (percentage of left ventricular myocardium that is infarcted muscle) = 41 ±  8.1%. 
tFigures given for derivative of left ventricular pressure represent statistics for changes in maximum positive 
values of derivative. Note that largest mean changes occurred in stroke power and stroke work, and that 
smallest ratio of standard deviation to mean values is for stroke power.
monary disease.7 Right atrial pressure is function curves (plot of stroke work against 
also poorly correlated with left ventricular right atrial pressure) is quite misleading, for 
end-diastolic pressure (LVEDP).8 Also, in right atrial pressure probably does not re­
chronic left ventricular dysfunction, pul- fleet LVEDP, which in turn is not indicative 
monary artery pressure may not be in- of left ventricular end-diastolic volume, and 
dicative of LVEDP.9 However, there is, in consequently fibre length. Finally, animal 
general, a high correlation (r =  0.93) be- studies have led to the conclusion that ven- 
tween pulmonary wedge pressure and left tricular function curves are not a reliable 
atrial pressure.10 It appears, therefore, that index of ventricular function.13 
the use of right heart pressures to reflect the The variables measured in this study 
pressure in the left ventricle is currently be- were assessed based on their correlation with 
ing reassessed. Furthermore, the assumption respect to three aspects of myocardial in- 
that LVEDP adequately reflects left ventri- farction: presence, size and site. To the best 
cular end-diastolic volume is not considered of our knowledge this type of correlation 
as being valid either.11 A poor correlation study has not been investigated previously.
(r =  0.06) has been reported between the
presence of myocardial infarction and the Presence of Infarct
magnitude of LVEDP.12 In light of the The results shown in Table III suggest
above findings, the use of left ventricular that, except for stroke power and work, car-
INFARCT SIZE (X) INFARCT SIZE (%)
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diovascular hemodynamic changes accom­
panying infarction are poorly correlated with 
the presence of the infarct. For all other 
variables, the changes accompanying the in­
farct were either positive or negative; the 
direction of change was unpredictable, which 
suggests that these variables are not reliable 
indicators of even the presence of the in­
farct. This is borne out statistically in that 
the standard deviations of the changes in 
such variables as ascending aorta pressure, 
cardiac output, heart rate, stroke volume, 
total peripheral resistance and derivative of 
left ventricular pressure are large relative to 
the mean change in these variables.
The literature on this topic is sparse, and 
in some cases the findings are conflicting. 
In general, however, the changes in the 
variables reported by others were similar to 
those we noted, except for stroke power and 
work. Braunwald14 and Karliner and Ross8
both reported a slight decrease in arterial 
pressure after myocardial infarction. Rush- 
mer15 stated that cardiac output is un­
changed after infarction, whereas Karliner 
and Ross8 as well as Freis and colleagues,16 
reported a slight decrease in this variable. 
The increase in cardiac output accompany­
ing infarction, noted for two of our dogs, is 
not uncommon.17 Rushmer15 reported that 
heart rate increased slightly on infarction 
and that stroke volume remained constant. 
Braunwald11 also stated that stroke volume 
remained unchanged but Freis and col­
leagues16 found that this variable decreased 
with infarction. Shillingford and Thomas,17 
and also Karliner and Ross,8 both reported 
that total peripheral resistance increased on 
infarction, a finding that is consistent with 
our own findings.
With respect to stroke work, we observed 
a mean decrease of 10.4%, with a standard
DOG NO 179 171 I D  177 178 180 182 193 194 195 196 198
INFARCT S IZE
%
M id -S lic e
APEX
DECREASE IN  
STROKE WORK -10 -
%
- 20-1
Fig. 3.—Findings in 12 dogs with respect to site of anterior myocardial infarction and corresponding 
alterations in stroke power and work. (Reference line is mid-slice of each heart.)
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deviation of ± 7 .8% . In this study, stroke 
work and stroke power were the only vari­
ables that consistently decreased in all the 
experimental animals. Braunwald14 sug­
gested that stroke work changes should 
parallel stroke volume changes. Fig. 4 shows 
stroke volume changes plotted against stroke 
work changes for the 12 dogs we studied. 
It does show a rather high correlation 
(r =  0.92) between the two variables, but 
it does not reveal the fact that, for two dogs, 
stroke volume increased +3%  and +10.6%  
and stroke work decreased by —4.8% and 
—0.5%. In other words, stroke volume 
changes were not consistent with the pres­
ence of the infarct, whereas stroke work 
consistently decreased because of infarction. 
Hamosh and Cohn18 found that stroke work 
decreased moderately with infarction. To the 
best of our knowledge, stroke power has 
not been measured and assessed with re­
spect to alteration with myocardial infarc­
tion. It may, however, be the most indi­
cative variable, because it incorporates the 
element of time and is a function of the 
velocity of contraction.r> Stroke volume and 
work do not take into account the rate at 
which the volume of blood is being removed. 
The results of these experiments indicate, in 
fact, that stroke power represents the hemo­
dynamic parameter with the largest mean 
change accompanying infarction (—10.7%) 
as well as the smallest deviation in the 
mean (±7 .1% ). Of the eight variables 
studied, stroke power was definitely the 
most indicative of the presence of the in­
farct.
Size of Infarct
Most of the methods of determining the 
size of an infarct have relied on the use of 
radioactive isotopes19- 20 or dyes.21 Griggs 
and Nakamura,19 for instance, used radio­
active iodine to determine the site of infarct 
by scanning the myocardium after an in­
farct had been created. Krug, Rochmont 
and Korb21 injected dye into feline hearts 
in order to assess the blood supply to re­
gions of the myocardium after an infarct. 
Pairolero and colleagues,22 are probably the 
only investigators who have artificially cre­
ated small and large infarcts in order to 
determine how the size of the infarct af­
fected energetics. However, the energetics
that were measured were LVEDP and car­
diac output, neither of which have been es­
tablished as good indicators of infarction.
Fig. 2 shows the correlations between the 
size of the infarct and the corresponding 
changes in stroke power and stroke work. 
The correlation coefficients of 0.22 and 
0.45 suggest that the alterations in energetics 
associated with myocardial infarction are 
not closely related to the size of the infarc­
tion.
Site of Infarct
Myocardial scanning23 and scintiphoto- 
graphy20 have been used to locate the site 
of infarcts. To our knowledge, correlation 
studies between infarct site and cardiovas­
cular dynamics have not been carried out. 
In regard to stroke power and stroke work, 
it appears from Fig. 3 that there is little 
correlation between these hemodynamic 
changes and infarct site.
Conclusion
The results presented in this paper show 
that the changes in cardiovascular hemo­
dynamics accompanying anterior myocardial 
infarction of 35 to 45% of the left ventricu­
lar myocardium are, except for stroke power 
and work, poorly correlated with the pres-
stroke work changes accompanying myocardial 
infarction in 12 dogs.
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ence, size, and site of infarction. Stroke 
power is the most accurate indicator of the 
presence of the infarction, but is not highly 
correlated with the size or site of the in­
farction. These results suggest that the most 
important hemodynamic parameter to 
monitor in the assessment of cardiac func­
tion is stroke power. Reliance on arterial 
pressure, heart rate, or cardiac output meas­
urements can lead to incorrect conclusions 
regarding the state of the myocardium.
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SURGERY FOR CORONARY ARTERY DISEASE AND 
CONGESTIVE HEART FAILURE*
P. BEDARD, MD, FRCS[C], W. J. KEON, MD, FRCSfCl, G  TAYLOR 
MD and Y. AKYUREKLI, MD, FRCS[C]
Summary: A  group of 41 patients presenting 
primarily with symptoms of congestive heart 
failure was investigated by coronary arterio­
graphy and myocardial revascularization. Of these 
patients 20 underwent resection of left ventricular 
aneurysm or left ventricular plication as well as 
revascularization. Revascularization plus resec­
tion of left ventricular aneurysm gives gratifying 
results, but revascularization in the presence of 
severe generalized hypokinesis is less satisfac­
tory; however, the improvement in clinical con­
dition in a sufficient number of patients is such 
that this approach to their management is 
justified. Accordingly, every patient with coro­
nary artery disease and congestive heart failure 
should be investigated by angiography. N u­
merous factors influence the results of revas- 
c>',~rization for the relief of congestive heart 
■re; the most useful as a criterion to aid 
ent selection is left ventriculography. In this 
P of 41 patients 66% were helped by m yo- 
dial revascularization.
sume: Nous avons etudie par arteriographie 
"onarienne et par revascularisation du m yo- 
de un groupe de 41 malades presentant: 
cipalement les symptomes d’une insuffi- 
- -  -o cardiaque globale. Parmi ces malades, 20 
ont eu une resection d'un anevrisme du ventri- 
cule gauche ou une plicature du ventricule gauche 
ainsi qu'une revascularisation. Cette derniere in­
tervention couplee avec la resection de I'anevris- 
me du ventricule gauche a donne des resultats 
satisfaisants, mais la revascularisation en pre­
sence d'une hypocinesie severe et generalises 
est moins satisfaisante. II faut cependant ad- 
mettre que ('amelioration clinique con state e chez 
un nombre suffisant de patients permet de 
justifier ce mode de traitement. II s'ensuit que 
tout malade presentant une maladie coronarienne 
et une insuffisance cardiaque devrait etre exa­
mine d'abord par angiographie. De nombreux 
facteurs exercent une influence sur les resultats 
de la revascularisation pratiquee pour ameliorer 
isuffisance cardiaque. Le critere le plus utile 
cur la selection du traitement est la ventriculo-
*From the University of Ottawa cardiac unit, 
Ottawa Civic Hospital, Ottawa, Ont.
Supported by the Ontario Heart Foundation.
Reprint requests to: Dr. P. Bedard, University of 
Ottawa Cardiac Unit, Ottawa Civic Hospital, 1053 
Carling Ave., Ottawa, Ont. KIY 4E9.
graphie gauche. Parmi notre groupe de 41 
malades, 66%  ont ete ameliores par une revas­
cularisation du myocarde.
In cases of congestive heart failure the re­
sults of myocardial revascularization may be 
disappointing. We believe the value of by­
pass grafting for congestive heart failure is 
still uncertain, and there is evidence that 
aortocoronary bypass does increase con­
tractility.1'3 This paper presents our ex­
perience with cardiac revascularization in 
patients with congestive heart failure.
M e t h o d
From February 1970 to April 1973 in­
clusive, 41 patients with congestive heart 
failure underwent cardiac revascularization. 
There were 40 men and 1 woman; their ages 
ranged from 38 to 66 years (average, 51 
years). The diagnosis of congestive heart 
failure was made only if the criteria of 
McKee et al4 were satisfied. Excluded from 
this study were the patients with a left ven­
tricular aneurysm or with an elevated left 
ventricular end-diastolic pressure (LVEDP) 
without clinical evidence of congestive heart 
failure.
Patients were classified clinically accord­
ing to the New York Heart Association 
classification; of the 41 patients, 18 patients 
were graded as class IV, 22 were graded as 
class III and 1 patient, class II (Table I). 
Among those in class IV, 7 required left 
ventricular reconstruction and 11 bypass 
grafting only; among those in class III, 13 
patients required left ventricular reconstruc­
tion and 9 did not.
The surgical procedure in all patients was
TABLE I.—P reoperative Classification of 41 
Patients with Congestive H eart F ailure
No. of patients
Class 
{NYH A)
Without L V  
reconstruction
With L V  
reconstruction
IV
(n =  18) 11 7
III
(n =  22) 9 13
II
(n =  1) 1 0
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performed under cardiopulmonary bypass 
with normothermia, hemodilution and a 
high perfusion flow. A vent was always in­
troduced at the apex of the left ventricle, 
and anoxic arrest was used in most patients. 
The operative procedures performed on 
these 41 patients were as follows: resection 
or plication of the left ventricle in 20, 17 of 
whom underwent resection of an aneurysm 
and 3 of whom underwent plication of the 
left ventricular wall; revascularization with 
bypass grafting in 37; internal mammary 
implants in addition to other procedures in 
23, and endarterectomy in 5 patients, among 
whom a total of eight endarterectomies were 
performed.
We also analyzed certain factors that 
might influence the operative results. These 
factors were angina; systemic hypertension; 
cardiomegaly as measured by cardiothoracic 
ratio; LVEDP; cardiac index; left ventri­
cular contraction as analyzed by a left ven­
triculogram in the RAO position; blood flow 
in graft; and reconstruction of left ventri­
cular wall.
R e s u l t s
The mortality in this group of patients 
was 24% ; 10 of 41 patients died. Two of 
the patients died within 3 weeks of opera­
tion and eight died between 3 weeks and 
29 months later. There were no operating- 
room deaths.
Of the 20 patients who underwent re­
construction of the left ventricle, the pre­
operative clinical grading was class IV in 
7 patients and class III in 13 patients. The
Fig. 1.—Preoperative (left) and postoperative (right) functional classification of patients re­ceiving aortocoronary bypass grafts and left ven­tricular reconstruction. Preoperative classification: open circle— class III, blocked circle— class IV (New York Heart Association classification).
postoperative course of those with class IV 
disease was as follows: two died, one was 
reclassified as having class III disease, two 
patients were reclassified as having class II 
disease and two patients as having class I 
disease. Of those with class III disease pre- 
operatively, one died, six were reclassified 
as having class II disease and six were re­
classified as having class I disease. Thus, of 
these 20 patients, 3 (15%) died and the 
condition of the remaining 17 (85%) was 
improved after operation (Fig. 1).
Of the 21 patients in whom revasculariza­
tion was performed without any reconstruc­
tion of the left ventricular wall, 11 were 
originally graded as having class IV disease,
9 as having class III disease and 1 as having 
class II disease. Among those with class IV 
disease, two patients died, two continued 
to have class IV disease, four were reclas­
sified as having class III disease, and three 
patients were reclassified as having class II 
disease. Of those with class III disease, five 
patients died, none became worse, two were 
no better, and two were judged to have 
class II disease. In the one patient whose 
disease was assessed as class II preoper- 
atively the condition was reclassified as class 
I postoperatively. As Fig. 2 shows, of these 
21 patients, 7 (33%) died postoperatively,
10 (48%) patients manifested improvement, 
and 4 (19%) noted no improvement. These 
last four patients when assessed for con­
gestive heart failure did, however, note that 
their angina was less severe.
With respect to the 10 patients who died.
blocked circle— class IV.
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in 1 angiography 8 weeks before death 
showed that both grafts were patent, and in 
2 of the 5 others in whom autopsy was 
performed the grafts were either completely 
or severely occluded.
D iscussion
Analysis of the various factors that can 
influence the outcome of surgery is useful 
in developing criteria for management. An­
gina was absent in only four patients. One of 
these patients died and two underwent re­
section of an aneurysm. Systemic hyperten­
sion was noted in three patients; two of them 
died, 7 and 29 months later, respectively.
Cardiomegaly and LVEDP were consi­
dered as factors in patients without a left 
ventricular aneurysm (Fig. 3). One patient 
with a normal cardiothoracic ratio and a 
normal LVEDP died but there were other 
patients with a high cardiothoracic ratio and 
elevated LVEDP whose condition improved. 
In some patients the LVEDP was low but 
the heart was enlarged; in others the cardio­
thoracic ratio was normal but LVEDP was 
elevated. Thus, in our patients, the cardio­
thoracic ratio and LVEDP were not useful 
as predictors of the outcome of surgery.
We also considered the cardiac index, 
the left ventricular contraction and the blood 
flows in the graft at the time of surgery, but 
none of these were useful as predictors of 
outcome. Ejection fractions were not deter­
mined in these patients. Bourassa et alr< and 
Solignac and Bourassa6 have described a 
classification of the left ventricular function 
using an “asynergy index”, which has en­
abled them to predict surgical prognosis, and 
this may prove to be the appropriate way 
of selecting patients for surgery.
In our experience, reconstruction of the 
left ventricular wall has been associated with 
an 85% improvement and this appears to 
be the only useful criterion with which to 
predict a possible outcome of surgery. Re­
ducing the left ventricular size by plication 
or resection of its noncontractile wall prob­
ably allows a more efficient contraction as 
the wall tension required to generate a given 
ventricular pressure is diminished, thus de­
creasing oxygen consumption. Direct myo­
cardial revascularization would also improve 
oxygenation in hypoxic regions of the myo­
cardium with improvement of the left ventri­
cular performance.1'3 Favaloro and his col­
leagues7 have reported a generally better 
prognosis after excision of an aneurysm if 
all three coronary arteries were not involved. 
Among recent reports, that of Spencer’s 
group8 indicates that there is an initial mor­
tality of 25% and an overall mortality of 
37% . The results were fair or good in 53% 
of patients. The left ventricle was recon­
structed in 45% of these patients; the mor­
tality was 38%. In Mundth’s series8 of 50 
patients, 25% underwent reconstruction of 
the left ventricle; the overall hospital mor­
tality was 15% and some postoperative im­
provement was noted in 60% . Kouchoukos 
et aV> resected aneurysms in nine patients 
who had congestive heart failure and re­
ported an overall mortality of 77% ; the con­
dition of neither of the two survivors was 
improved. Aldridge10 followed 20 patients 
with severe left ventricular dysfunction 
treated medically and found that 65% of 
them were dead at the end of 5 years, the 
condition of the survivors not having im­
proved throughout this period. The difficul­
ty in assessing these results stems from the 
wide variety of patients presenting with con­
gestive heart failure secondary to coronary 
artery disease. Thus, only a precise and 
widely accepted set of criteria of left ventri­
cular function will allow one to make a 
proper assessment of surgery in this group 
of patients; the most useful criterion is a 
proper analysis of the left ventriculogram.
Conclusion
Patient:
6 5 -
o
with congestive heart 
o
+
o +
0
0
0
4 5 -  .___________
^ T "  i i I T T
+  Dead 5 10 15 20 25 3 0 3 5
• Not im proved L V E D P  mm Hg
0  Im proved
failure
Fig. 3.—Cardiothoracic ratio and left ventri­
cular end-diastolic pressure in patients without 
ventricular reconstruction.
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should be investigated by angiography. If 
an aneurysm is present and resectable, or if 
a large left ventricular cavity can be reduced 
in size, the condition of these patients can 
be improved by aneurysmectomy or plication 
and revascularization. If there is no angio­
graphic evidence of ventricular aneurysm 
but severe ventricular dysfunction, re­
vascularization led to improvement in some 
patients. Although results of revasculariza­
tion in patients with severe ventricular dys­
function are obviously disappointing, we be­
lieve that investigation and surgical man­
agement of such patients should be pursued 
until more information becomes available. 
Currently, surgical treatment offers the only 
hope of rehabilitating many of these ter­
minal patients to a point where they can be 
discharged from hospital.
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PROPHYLACTIC ANTIBIOTIC THERAPY IN SURGERY*
LLOYD D. MacLEAN, MD, FRCS[C]
Summary: Prophylactic (preventive) antibiotic 
therapy initiated preoperatively, with antibiotics 
administered in moderately high dosage for short 
periods, is recommended on the basis of ex­
perimental and prospective, randomized clinical 
trials for patients who require surgery that is 
likely to expose tissue planes to contamination. 
The value of prophylactic antibiotics in clean 
operations is not presently supported but must 
be considered in patients with decreased resist­
ance and in those in whom infection of a pros­
thesis would have catastrophic results. In these 
patients topical antibiotics might prove useful 
and less dangerous.
It is clear that surgical technique remains an 
important but as yet unmeasured factor in 
wound infection.
Resume: L'antibiotherapie preventive entreprise 
durant la periode preoperatoire, avec des poso- 
logies moderement elevees d'antibiotiques pen­
dant de breves periodes, nous parait recom- 
mandable, si nous nous basons sur des essais 
cliniques faits au hasard, a titre d'experience et 
de prospective, chez des malades devant subir 
une operation susceptible d'exposer des plans 
tissulaires a la contamination. La valeur de I'anti- 
biotherapie prophylactique dans les operations 
exemptes de risque de contamination n'est 
actuellement pas admise, mais doit etre envi­
sages chez les malades dont la resistance est 
affaiblie et chez ceux ou I'infection d'une pro- 
these pourrait avoir des consequences desas- 
treuses. Chez ces malades, I'emploi local d'anti­
biotiques pourrait s'averer utile et est, de toute 
fapon, moins dangereux.
II est Evident que la technique chirurgicale 
demeure un facteur tres important relatif a la 
prevention de I'infection des plaies, mais qu'il 
est malheureusement encore neglige, faute 
d'etre evalue a sa juste mesure.
*From the department of surgery, Royal Victoria Hospital and McGill University, Montreal, Que.
Presented at the regional meeting of the Royal College of Physicians and Surgeons of Canada Montreal, Que., Oct. 3, 1974.
Supported by a grant from the Medical Research Council of Canada.
Reprint requests to: Dr. L. D. MacLean, Surgeon- in-Chief, Royal Victoria Hospital, 687 Pine Ave. W., Montreal, Que. H3A 1A1.
T h e  indiscriminate administration of anti­
biotics given prophylactically, based original­
ly on the mistaken idea that they might be 
useful but certainly could do no harm, is 
no longer acceptable. The emergence of re­
sistant strains, their failure to control sur­
gical infections, their cost, and the clinical 
masking of infections amenable to surgical 
therapy are the main reasons for condemn­ing this policy.
Despite these adverse effects, the selective 
use of antibiotics to prevent infection in sur­
gical practice is an important adjunct to 
care. The acceptance of this newer concept 
is based on the experimental demonstration 
that preoperative treatment is necessary, 
clinical evidence that the organisms in the 
wound at the conclusion of the operation 
cause the infection, and results of several 
supporting trials that were prospective, 
double-blind, and randomized. This com­
munication evaluates the experimental 
evidence supporting prophylactic antibiotic 
therapy and offers some clinical guides.
Classification of Wounds and
R isk of Infection
A purulent wound is generally agreed to 
be infected. The classification of wounds de­
fined by the National Research Council and 
the National Academy of Sciences is most 
useful in determining patients at risk.1
1. Clean.— A wound is clean if, during an 
operation, the gastrointestinal and respira­
tory tracts were not entered, if no inflam­
mation was encountered and if there was no 
break in aseptic technique. Hernia repair, 
thyroidectomy and appendectomy “en pas­
sant” are included in this category.
2. Clean-contaminated.— “Clean” opera­
tions during which the gastrointestinal or 
respiratory tract, or both, are entered but 
without appreciable spillage produce clean- 
contaminated wounds.
3. Contaminated.—A surgical wound is 
contaminated if there is either acute inflam­
mation (without pus formation) or gross 
spillage from a hollow viscus. Fresh trau­
matic wounds and operations in which there
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is a major break in aseptic technique are 
included in this category.
4. Dirty.— In cases of either a purulent 
operative site or a perforated viscus a wound 
is said to be dirty. Included in this category 
are old traumatic wounds.
The risks of infection in these four cate­
gories in one large study were as follows: 
clean wounds, 1.8%; clean-contaminated, 
8.9%; contaminated, 21.5%; and dirty, 
38.3% .2
Evidence Favouring Preoperative 
Treatment
Epinephrine injected into tissues of expe­
rimental animals decreases host resistance 
to an inoculation of bacteria, as measured 
by the size of the lesion. The increase in le­
sion size, reflecting the most severe decrease 
in host resistance, is greatest when the ische­
mia produced by adrenalin occurs at the 
same time as the bacteria are introduced; 
if the onset of ischemia is delayed 3 hours 
after bacterial inoculation, the resulting le­
sion is not different from those of controls.3 
Similar findings have been reported for 
shock caused by bacterial toxins or the in- 
traperitoneal injection of hypertonic glu­
cose.4 The skin infections caused by Sta­
phylococcus aureus, Pseudomonas pyocya- 
neus and Clostridium welchii became more 
serious only if the shock period was within 
2 to 3 hours of the intradermal injection of 
these bacteria.
The short decisive period of increased 
host susceptibility also applies to the bac­
teria in the lesions. Infections 3 to 5 hours 
old are not alleviated by intravenous anti­
biotic therapy in doses that are effective 
when given earlier.3 The diameter of the 
lesion 24 hours after the intradermal injec­
tion of S. aureus into guinea pigs is directly 
related to the time of injection of the anti­
biotics. The most effective time for anti­
biotic administration preceded the inocula­
tion of bacteria.6
These studies permit one to conclude that 
if prophylactic antibiotic therapy is to be 
used it should be started before the incision 
is made.
Indications for Prophylactic
A ntibiotic Therapy
In considering when prophylactic anti­
biotic therapy is indicated, it is reasonable 
to select those operations in which there is 
definite risk of infection; these are oper­
ations producing clean-contaminated, con­
taminated and dirty wounds. Most infec­
tions in these instances are caused by gram­
negative organisms and originate from the 
patient; they differ from infections caused by 
5. aureus which are usually air borne. This 
question has been carefully studied by 
Thomsen, Larsen and Jepsen7 who, by 
phage-typing and serotyping, traced the 
source of wound infections associated with 
Escherichia coli and S. aureus. They found 
that with E. coli of the same serotype as of 
the organism causing the wound infection 
after an abdominal procedure the organisms 
usually originated in the organ being oper­
ated on. In contrast, the staphylococcal in­
fections almost always originated in air 
samples from the ward rather than from 
either the patient or the operating theatre 
environment. For the E. coli group of in­
fections, prophylactic measures should be 
directed against contamination at the time 
of surgery in predictable surgical problems.
With staphylococcal infections it is prob­
able that there are a multitude of sources 
and routes of infection and that no simple 
measure would suffice as a prophylactic pre­
caution. Control of infection with S. aureus 
at other sites in patients, in the operating 
room air, in the ward air and in hospital per­
sonnel are probably all implicated on occa­
sion. Currently, it is not practical to treat all 
patients at risk with antibiotics that are ef­
fective against S. aureus, nor is it possible 
to predict a high-risk group as has been 
done in the case of gram-negative infections.
A useful adjunct to prophylactic antibio­
tic therapy is routine intraoperative wound 
culture. This provides the best indication as 
to the causative organisms and to the ap­
propriate antibiotic when clinical infection 
develops. Polk8 found that a positive culture 
of material taken from the subcutaneous tis­
sue after the fascia had been closed was the 
most accurate prognostic indicator of wound 
sepsis and that the results of culture were 
useful in selecting the appropriate antibiotic. 
Polk’s study was of a prospective trial. 
Wound culture during closure was also the 
most useful of 14 variables examined in a 
regression analysis by Davidson, Clark and
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Smith.9 These workers computed the relative 
importance of variables known to be associa­
ted with increased risk of wound infection. 
These variables included, among others, the 
following:
1. Concentration of bacteria in the wound 
at the end of the procedure.
2. Age of the patient.
3. Duration of the operation.
4. Contamination during the operation.
5. Patient’s hospital environment (i.e. 
whether the patient was from an open ward 
or a single room).
6. Occurrence of glove punctures.
7. Nasal carrier state.
8. Operative urgency (i.e., whether or not 
the procedure was an emergency).
9. Absence of skin towels, use of a drain. 
Only the first five factors were judged to 
be contributory and the positive culture from 
the subcutaneous layer at the time of closure 
was by far the most important in determin­
ing the ultimate behaviour of the wound. In 
this study a positive wound culture was more 
than three times as important as any other 
single factor.
The value of prophylactic antibiotic thera­
py is confirmed by the results of several ran­
domized trials. Table I summarizes the find­
ings for patients undergoing operations in 
the clean-contaminated, contaminated and
dirty categories.10"17
Washington and colleagues10 assessed the 
value of neomycin alone, neomycin with te­
tracycline, and a placebo in bowel prepara­
tion for colon surgery. The study was dou­
ble-blind and randomized on a total of 196 
patients; all were operated on by the same 
surgeon. A wound infection rate of 43% 
was reported for the placebo group and of 
41% for the neomycin group, in contrast 
to an infection rate of 4.6% for the neomy­
cin-tetracycline group. No case of pseudo­
membranous enterocolitis was reported in 
any of the groups.
The study of Andersen, Korner and 0ster- 
gaard11 supports the additional use of 
topical antibiotics in preparation for colon 
surgery. They studied the results in 240 
patients with cancer who underwent surgery 
on the colon or rectum. Mechanical pre­
paration was used in all patients, and all but 
55 patients with low rectal carcinomas re­
ceived neomycin sulfate and chlorchinaldole 
for 3 days before operation. In the treat­
ment group ampicillin powder (1 g) was 
applied to the subfascial and subcutaneous 
spaces at the time of wound closure. The 
control group had a wound infection rate 
of 18.3%, the ampicillin powder group, 
2.5% .
Rickett and Jackson12 demonstrated the
TABLE I.—Prospective, Randomized Trials of P rophylactic Antibiotic T herapy in Operations
with H igh R isk of Infection
Antibiotic
therapy
Infection rate (%)
Author(s) Operative site Experimental group Control group
Washington et al10* Colon Neomycin and 
tetracycline
4.6 43
Andersen, Korner 
and Ostergaard11)
Colon and rectum Ampicillin
(topical)
2.5 18.3
Rickett and Jackson12* Appendix Ampicillin
(topical)
3 24
Bernard and Cole13 Gastrointestinal 
and biliary tracts
Penicillin G,
methicillin,
chloramphenicol
8 27
Fullen, Hunt and 
Altemeier14
Penetrating 
wounds of 
abdomen
Penicillin and 
tetracycline or 
chloramphenicol
7 30
Polk and Lopez - 
Mayor16
Gastrointestinal
tract
Cephaloridine 6 29
Hughes et al16* Colon Penicillin G 12.5 58
Chetlin and 
Elliott17
Biliary tract Cephaloridine 4 27
* Double-blind study. 
fTriple-blind study.
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value of topical ampicillin powder at the 
time of appendectomy in a double-blind 
study. In a 5-month period all patients un­
dergoing appendectomy were included ex­
cept those who reported a sensitivity to pe­
nicillin. The study included patients who 
were being operated on for acute appen­
dicitis as well as those undergoing “cold” 
appendectomy. The group that received 
the ampicillin had a wound infection rate of 
3% and the controls, 24%.
The retrospective study of Fullen, Hunt 
and Altemeier14 concerning 295 patients 
supports the preoperative administration of 
antibiotics in patients with penetrating 
wounds of the abdomen. Antibiotic therapy 
started before operation was associated with 
a wound infection rate of 7% , whereas 
therapy started during or after operation 
resulted in rates of 33 and 30% respect­
ively.
Polk and Lopez-Mayor15 obtained con­
vincing results in a randomized trial of 199 
patients in whom therapy was started be­
fore operation. They noted a definite dif­
ference in wound infection rates associated 
with surgery on the gastrointestinal tract de­
pending on whether or not the patient re­
ceived antibiotics. The patients in the treat­
ment group received cephaloridine, given 
parenterally 1 g on call to surgery, 1 g at 5 
hours and 1 g at 12 hours thereafter. 
Planned surgery on the biliary tract was ex­
cluded. In the treated group the wound 
infection rate was 6%, in contrast to a rate 
of 29% in the controls. Emergence of re­
sistant strains was not detected.
A similar regimen was used prospectively 
(not double-blind) by Chetlin and Elliott17 
in 84 patients undergoing biliary tract sur­
gery with a high risk of infection. The high- 
risk category included one or more of the 
following variables: age over 70 years, acute 
cholecystitis, obstructive jaundice or com­
mon duct stones without jaundice. Invasive 
infections occurred in only 4% of 47 treated 
patients but in 27 % of similar but untreated 
controls.
The evidence for prophylactic antibiotics 
in the categories covered by these studies 
is convincing. Changes in sensitivities might 
alter this opinion in the future and this em­
phasizes the need for continued evaluation 
of results.
Indications for Prophylactic
Therapy Before Clean Operations
There are two situations in which prophy­
lactic antibiotic therapy might be considered 
for clean surgical procedures: (a) when 
operations are performed on infection-prone 
individuals, and (b) when permanent pros- 
theses are inserted.
Evidence to support this approach is not 
as easily obtained as for the other categories 
of contamination. Boyd, Burke and Colton18 
noted that, after operation for hip fracture, 
prophylactic antibiotic therapy was associ­
ated with a decrease in wound infection rate 
among 417 patients. Nafcillin was used ran­
domly and in a double-blind fashion starting 
before operation. The wound infection rate 
in controls (glucose group) was 4.8%; in 
the patients who received nafcillin it was 
0.8% (P < 0.05). This study supports the 
prophylactic use of antibiotics in “clean” 
operations in which the risk of infection 
was increased because of hematoma forma­
tion and the use of anticoagulant therapy.
A study on patients at increased risk that 
compared the topical use of antibiotics in 
renal transplantation is of interest. Two 
groups were studied: patients with primary 
renal transplantation incisions (group I) and 
patients who required re-exploration (group 
II). In patients of both groups the wound 
was irrigated with 50 000 units of bacitracin 
and 1 g of neomycin in 200 ml of saline. 
In group I the wound infection decreased 
from 5.0 to 2.5% (P < 0.02) and in group 
II, when the patients were receiving im­
munosuppressive agents, from 28.6% to 
4.8% (P < 0.001).19
Patients in whom foreign materials are 
implanted commonly receive prophylactic 
antibiotic therapy, but there is no firm scien­
tific support for this practice. In such pa­
tients the causative organism rather than the 
infection rate may change.
Conclusions
1. The value of antibiotics given prophy- 
lactically for short periods (2 to 4 doses) 
starting before operation when the proce­
dure contemplated is likely to be clean- 
contaminated, contaminated or dirty is sup­
ported by basic research as well as con­
trolled clinical trials.
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2. The value of prophylactic antibiotic 
therapy in patients undergoing clean opera­
tions is currently not supported by evidence. 
However, this form of therapy may prove 
useful for patients with decreased resistance 
to infection or for those in whom infection 
of a prosthesis would have catastrophic 
consequences. Local irrigation with antibio­
tics is useful for some of these patients.
3. The preoperative identification, by im­
munologic testing, of patients who have de­
creased resistance is likely to become a use­
ful adjunct to infection control in the hos­
pital and in the surgical patient.
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In pre-Listerian days wound infection was the 
rule; after amputation, 4 of every 10 patients 
were lucky to survive. In 80 years all this changed, 
owing largely to the benefits of three classes of 
antibacterial agents: those represented by CAR­
BOLIC ACID, CHEMOTHERAPEUTIC DRUGS 
(like 2,4-diaminobenzene-4-sulfonamide [Pronto- 
sil]) and PENICILLIN.
A handful of 19th century pioneers and 20th 
century trailblazers in fields outside surgery made 
today’s sophisticated surgery safe— men like 
Pasteur, Ehrlich, Domagk and Fleming. Their 
stories we know in outline but the finer details of 
their contributions are less well known, but 
fascinating (and surprising) even so.
Carbolic acid was first used in surgery by 
Lister in 1865, in dressing a compound fracture. 
But preceding Lister had been the ancient Egyp­
tians, who used coal tar and pitch to prevent their 
mummies rotting; Pasteur, who demonstrated the 
bacterial cause of putrefaction; the Germans, who 
used carbolic acid to stop putrefaction; and the 
English, who used carbolic acid to disinfect sew­
age.
Useful as it was, carbolic acid was caustic. 
Other chemicals were sought. Ehrlich, who coined 
the word “chemotherapy” , believed tissues had an 
affinity for dyes and he paved the way for Ger­
man industrial chemists to develop dye derivatives 
to cure disease. Domagk was one such man. His 
boss, Horlein, wanted a drug that would kill 
streptococci; but he also wanted the drug to be 
kept secret— and, cannily, patented. Domagk duly 
synthesized Prontosil. Patented at Christmas 1932, 
Prontosil did remain unknown— and unavailable— 
outside Germany for some 3 years; it was the 
first o f many “wonder drugs” to control infection.
The discovery of penicillin is a romantic story. 
We recognize Fleming as the discoverer, in 1929. 
But he was not: Gosio (1896), Duchesne (1897), 
Sturli (1908) and Gratia and Doth (1925) earlier 
had recognized the antibiotic powers of the Peni- 
cillia. History, though, has favoured the Scotsman.
It remains necessary to return to Pasteur, who 
convinced Lister that blood poisoning and gan­
grene were bacterial manifestations. It was with 
Pasteur that antimicrobial therapy really began. 
Besides demonstrating the bacterial nature of 
putrefaction, he formulated, prophetically, the 
vital ecologic concept o f antibiosis. (Vuillemin 
actually introduced the word, in 1889.) Two 
germinal statements of Pasteur, written in 1877, 
say it all: "La vie empeche la vie” (“Life hinders 
life” ) and “Tous ces faits autorisent peut-etre les 
plus grandes esperances au point de vue thera- 
peutique" (“AU these facts justify the greatest 
hopes for therapeutics”).
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RENOVASCULAR HYPERTENSION:
THE CONTRIBUTION OF SURGERY TO TREATMENT*
JEAN E. MORIN, MD, FRCS[C]►
Summary: Surgical treatment for renovascular 
hypertension resulted in either improvement or 
cure in 25 of 28 patients. Surgical treatment of 
» hypertension, however, is indicated in only a 
very small group of patients, and preoperative 
► selection of patients and technical details of the
appropriate operative procedure still have to be 
■ perfected.
Resume: Le traitement chirurgical de I'hyper- 
tension renovasculaire nous a permis d'obtenir 
une amelioration ou une guerison chez 25 mala- 
des sur 28. Toutefois, le traitement chirurgical de 
I'hypertension n'est indique que chez un tres 
y  petit groupe de malades. Par ailleurs, le choix
preoperatoire des malades et les details tech­
niques de la methode operatoire doivent encore 
etre perfectionnes.
*From the division of cardiovascular surgery, 
McGill University, Montreal, Que.
Presented at the regional meeting of the Royal 
College of Physicians and Surgeons of Canada, 
Montreal, Que., Oct. 3, 1974.
Reprint requests to: Dr. J. E. Morin, Division of 
Cardiovascular and Thoracic Surgery, McGill 
University, Royal Victoria Hospital, 687 Pine 
Ave. W., Montreal, Que. H3A 1A1.
Surgically correctable hypertension ac­
counts for only 10% of all cases of hyper­
tension, and, among patients with this form 
of hypertension, the causative mechanism of 
hypertension can be traced to the renovas­
cular apparatus in only one-half. Great pro­
gress has been made in case identification 
and surgical treatment, but perfection has 
not yet been attained. In this paper diag­
nostic features of renovascular hypertension 
and surgical forms of treatment are de­
scribed and, in addition, surgical treatment 
is evaluated in a series of 28 patients with 
renovascular hypertension.
C linical , L aboratory and
R adiographic F ea tu r es , and
Surgical T echnique
The clinical features in the patient with 
renovascular hypertension differ little from 
those in the patient with essential hyperten­
sion, and it is still difficult for the clinician 
to decide whether a specific patient should 
undergo a complete investigation. Family 
history, recent onset of hypertension, and 
rapid acceleration of hypertension do not
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reliably differentiate these two etiologic 
groups.1 Only an abdominal bruit provides 
a definite clue to a vascular lesion as the 
basis for the hypertension.
The renal vein renin can be of value in 
patient selection; its determination is most 
significant when the patient has been on a 
low-salt diet, has taken furosemide, and has 
been ambulatory for 2 hours prior to the 
determination.
Arteriography is still the most informative 
investigation. In addition to assessing renal 
function, it provides an accurate anatomic 
picture of the lesion (Fig. la). Magnification 
views are most useful in the detailed assess­
ment of the pathologic process and of the 
planning of precise reconstruction (Fig. lb).
The surgical procedures to correct renal 
artery obstructions include endarterectomy 
with or without patch graft, and bypass 
graft. Endarterectomy associated with a 
patch graft is mainly for patients presenting 
with arteriosclerotic plaques. The pathologic 
process is such that an appropriate proce-
Fig. 2.—Diagrammatic representation of endar­
terectomy at site of renal artery stenosis (a) and 
Dacron patch-graft for arteriosclerotic plaques in 
renal artery (b).
dure is an endarterectomy completed by an 
angioplasty with light-weight, knitted Da­
cron patch; the procedure opens the mouth 
of the renal artery widely at its take-off from 
the aorta (Fig. 2). This can usually be best 
performed through a long transabdominal in­
cision. The bypass graft using the greater 
saphenous vein is more appropriate for distal 
or extensive renal artery involvement, as in 
most cases of fibromuscular dysplasia (Fig. 
3). This can be achieved on the left from a 
transabdominal approach, and on the right 
from a retroperitoneal approach.
R e s u l t s  o f  T r e a t m e n t
A series of 28 patients, seen in the period 
from 1966 to 1974 inclusive, with severe 
diastolic hypertension ranging from 90 to 
160 mm Hg, uncontrollable by medication, 
and renal artery lesions on arteriography, 
were treated surgically and followed. The 
etiopathogenetic factor was arteriosclerosis 
in 19 patients (predominantly men) and 
fibromuscular dysplasia in the other 9 pa­
tients (more frequent in women). In the 
evaluation of the results, the patient is con­
sidered cured if the diastolic pressure is be­
low 90 mm Hg without medication, and im­
proved either when the diastolic pressure 
has decreased by 20 mm Hg or where there 
is an adequate response to medical therapy. 
A failure is recorded when there is no 
change.
Results can be assessed according to 
etiologic considerations and according to the 
operative procedure. On the basis of etiol­
ogic differentiation, 50% of the arterioscle-
Fig. 3.—Replacement of abnormal renal artery 
(left) by saphenous vein bypass graft (right) for 
fibromuscular dysplasia.
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TABLE I.—Results of Treatment Based on Etiologic Lesion and on Operative Procedure in 28
Patients
Clinical result and no. of patients
A- Basis of assessment of result Cure Improvement Failure
Etiologic lesion:
Arteriosclerosis (n =  19 )....................................................... ................  9 7 3
Fibromuscular dysplasia (n =  9 )................................. ................  7 2 0
y
Operative procedure:
Saphenous vein bypass graft (n =  6 ) ............................... .................. 6 0 0
Angioplasty (n =  1 5 )............................................................. ................ 8 6 1
Dacron graft (n =  2 ) ............................................................. ................ 0 1 1
V Nephrectomy (n =  5 ) ............................................................ ................ 2 2 1
TABLE II.—Correlation Between Renal Vein Renin Determinations and Clinical Results
Renin value
Renal vein
0 Renin ratio 
R:L
Site of
lesion /  operation*
Clinical
result CorrelationfPatient R L IVC
►
i Nd{ Nd
Determination of renin value as ng/1- min 
— — L/BP Improved NA
2 Nd Nd — — R/BP Failed NA
3 12.5 20.8 — 1.6 L/N Cured +
H 4 Nd Nd — •— R /P Cured NA
5 13.9 20.8 — 1.5 R/E, L /P Failed —
6 69.4 34.9 — 1.9 R /P, L /P Cured +
7 45.1 34.0 — 1.3 R /P Cured
8 41.6 69.4 — 1.4 L /P Curedy 9 13.9 1153.0 — 82.9 L /P Improved -
10 69.4 62.0 — 1.3 L/P Improved —
11 432.0 139.0 — 3.1 L/P, R /N Cured +
12 49.9 95.7 — 1.9 L /P Improved +
k. 13 6.6 21.7 — 3.2 L/BP Cured +
14 22.9 84.5 — 3.6 L/P Cured +
15 24.3 13.9 — 1.7 R/N , L /P Failed
16 164.0 278.0 — 1.6 R/P, L /P Cured +
17 21.6 7.1 — 3.0 R/BP Cured +A * 18 13.9 15.5 — 1.1 L/E Improved
19 115.7 52.3 — 2.2 R/BP Cured +
20 12.9 0 — — R /N Cured +
k
21 22.0 54.0
Determination of renin value as ng/ml • h§ 
Nd 2.4 L /P Cured +
22 40.4 30.8 30.9 1.3 R /N Improved —k 23 4.3 5.3 3.9 1.2 R/BP Cured —
24 42.5 17.9 14.3 2.3 R /P Improved +
25 29.4 93.3 Nd 3.1 L/N Improved +
26 2’0 6.9 1.4 3.4 L/BP Improved +
4 27 5.49 6.41 Nd 1.3 R/BP Cured —
28 2.5 1.9 1.3 1.3 R/BP Cured —
g  *BP = bypass graft, P = patch angioplasty, E = endarterectomy, N = nephrectomy.
[ fRenin value on side of lesion greater by factor of ^1.5 than value on normal side. +  =  positive correlation,
I — = no correlation, NA = not applicable.
{Nd = not determined.
§As from February 1973.
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rotic patients (9/19) were cured, 35% 
(7/19) were improved and 15% (3/19) were 
no better; and 75% (7/9) of those with 
fibromuscular dysplasia were cured and 
25% (2/9) were improved (Table I).
When the results were assessed on the 
basis of the operation performed, the 
saphenous vein bypass graft, when it could 
be constructed satisfactorily, yielded the 
highest cure rate and the endarterectomy 
plus angioplasty yielded a cure rate of only 
50% , being done mainly for arteriosclerosis 
(Table I).
The renal vein renin values correlated 
with the expected result (the result deter­
mined by postoperative blood pressure meas­
urement) in only 15 out of 25 patients 
(Table II).
Our total experience is summarized in 
Fig. 4. We consider 16 patients as cured; 
they have been followed up from 6 years 
to a few months. One patient died after 
2 years but with a normal blood pressure, 
and one patient who was cured cannot now 
be traced, but on the last follow-up visit his 
blood pressure was normal. In nine patients 
the condition improved, though one cannot 
now be traced. Of the three patients whose 
condition did not improve, two died early 
and one still has severe hypertension.
C o m m e n t
The discovery of the relationship between 
renal ischemia and hypertension has gen­
erated much enthusiasm for surgical treat­
ment of renal hypertension. But if results 
are sometimes excellent, they are also very 
often disappointing.2 The reason for this 
is the difficulty in identifying patients with 
reversible vascular lesions. Preoperative in­
vestigations are now more precise than they 
once were, but they still have to be per­
fected. Finally, an excellent correlation be­
tween the preoperative investigation and the 
result presupposes a perfect surgical repair 
without morbidity or mortality. This has not 
yet been achieved. The type of lesion and 
the location of the renal artery make the sur­
gical repair difficult, and it is only with more 
experience that the surgical procedures can 
be improved.
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• preserves 
lysosome and 
cell membranes, 
thereby preventing 
the release of destruc­
tive lysosomal enzymes3
• preserves platelets 
thereby reducing the risk
of intravascular coagulation1
• preserves leukocyte in­
tegrity thereby helping to main­
tain the pulmonary architecture1
solu-Medroi
helps reduce 
pulmonary 
damage 
and increase 
survival rates
The recovery of patients in shock 
is often complicated by a pattern of 
deteriorating pulmonary function. 
This pulmonary insufficiency pro­
gresses despite restoration of haemo­
dynamic balance and apparent stabili­
zation of the acute episode.
Under conditions of prolonged shock, 
lack of oxygen at the cellular level 
causes alterations in the oxygen-carbon 
dioxide exchange mechanism. These 
changes in cell metabolism lead ultimately 
to interstitial oedema and perivascular 
haemorrhage.1 Polymorphonuclear leuko­
cytes aggregate in the pulmonary capillaries 
and obstruct the pulmonary vascular bed. 
As these trapped cells break down, they 
release lysosomes, tiny subcellular par­
ticles containing proteolytic enzymes.1 
These enzymes attack their host cell and 
go on to damage or destroy other cells.2 
The resulting tissue damage may not 
readily repair itself even if the shock 
patient survives.
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HOST DEFENCE MECHANISMS: EVALUATION AND ROLES OF 
ACQUIRED DEFECTS AND IMMUNOTHERAPY*
JONATHAN L. MEAKINS, MD, DSc, FRCS[C]
Summary: The development of an infectious 
process is a result of the interaction of the three 
determinants of infection: the infecting organ­
ism, the local site of infection and systemic 
host defences. Interaction of the various com­
ponents is important in an understanding of the 
development of sepsis. Acquired defects of host 
defence mechanisms are attributable to a variety 
of factors and can be both the cause and the 
result of sepsis. The burn injury illustrates al­
terations in host defence and the interaction of 
the determinants of sepsis. Methods of evaluat­
ing the components of host defence are avail­
able, though sometimes difficult; in the future, 
evaluation of the effect of one component on 
another will become clinically feasible, allowing 
more complete assessment of acquired defects. 
Immunotherapy is not yet widely available; how ­
ever, definition of the acquired defects of host 
defence mechanisms in surgical patients may 
eventually lead to introduction of effective treat­
ment.
Resume: L'evolution d'une infection s'effectue 
suivant I'interaction des trois facteurs qui la de- 
terminent: I'organisme pathogene, le siege local 
de I'infection et les mecanismes immunitaires 
de I'hote. Si on veut comprendre le developpe- 
ment de I'infection, il importe de saisir I'interac- 
tion des divers facteurs. Les deficiences immu- 
nologiques acquises dans les mecanismes im­
munitaires sont attribuables a une grande va- 
riete de facteurs et peuvent etre a la fois la 
cause et le resultat de I'infection. La lesion par 
brulure illustre bien les alterations qui se 
produisent chez le blesse et i'interaction des 
determinants de I'infection. On possede des 
moyens d'evaluer les composants des mecanis­
mes immunitaires, mais ils sont encore difficiles 
d'acces. A  I'avenir, revaluation de l'effet 
qu'exerce un facteur sur un autre deviendra ac-
*From the departments of surgery and micro­
biology, Royal Victoria Hospital, and McGill 
University, Montreal, Que.
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ment of Surgery, Royal Victoria Hospital, 687 
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cessible en Clinique, ce qui permettra d'evaluer 
plus completement les deficiences acquises. 
L'immunotherapie n'est pas encore une thera- 
peutique largement etablie, mais une evaluation 
plus precise des deficiences acquises des m e­
canismes immunitaires du malade opere pourra 
finalement rendre le traitement plus efficace.
Wound  infection, deep sepsis and septice­
mia continue to be common surgical prob­
lems.1- 2 The development of any one of 
these septic processes is a result of the in­
teraction of the three determinants of in­
fection; bacteria, environment and host de­
fence mechanisms (HDM). The relative im­
portance of each determinant is schematic­
ally represented in Fig. 1; in this instance 
the normal situation reflects homeostasis, a 
state of balance resulting in an absence of 
infection. The bacterial determinant com­
prises the set of potential pathogens and 
their virulence factors that might become 
important in an infection; for example, the 
bacterial contamination of a compound 
fracture or pathogenic properties of /J-hemo- 
lytic streptococcus when in the tissues. The 
environment comprises the site of infection 
and local factors that, when changed, allow 
infection to develop (Table I). The ability
Fig. 1.—Interaction of determinants of infection. 
Point of intersection of three circles represents 
zero probability of sepsis and homeostasis—normal 
state of no infection.
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TABLE I.- Nature and Function of Environment and Host Defence Mechanisms
Determinant Nature of determinant Function of determinant
Environment (Local factors) Mechanical barrier 
Biologic decontamination 
Mechanical component 
Chemical component 
Normal flora
Prevention of lodgement
Host Defence Mechanisms 
(Systemic factors)
Inflammatory component 
(vascular, cellular and molecular) 
Humoral component 
Phagocytic component 
Cellular immunity 
Complement
Containment and resolution
of the potential site to prevent lodgement 
of organisms and resist infection is a func­
tion of effective local defence factors. Local 
or environmental factors may be destroyed, 
as with a compound fracture or burn injury, 
both of which permit the bacteria easier ac­
cess to the internal milieu. The host defence 
mechanisms, the third determinant, consist 
of the systemic response to bacteria at a 
potential site of infection and this deter­
minant incorporates the immunologic re­
sponse to infection (Table I).
Enlargement of the area of intersection 
of the three determinants of sepsis (Fig. 2) 
is a function of bacterial properties of viru­
lence, a breakdown in the environment or 
a failure of systemic HDM. Fig. 2 depicts 
the resultant area representing the probabil­
ity of infection for a burn injury, after which 
local factors are obviously altered and there 
are acquired defects of HDM.
Many of the practical aspects of surgery 
are aimed at preventing infections. Operating 
room practice and surgical technique are 
directed towards the control of numbers and 
types of bacteria having access to wounds 
and to making these wounds unsuitable for 
growth of bacteria. These practices include, 
for example, aseptic and antiseptic tech­
niques, hemostasis, reduction of dead space, 
and gentle handling of tissue. It is likely 
that HDMs that cannot now be suitably 
manipulated dictate to a significant extent 
the development of an infectious process.3
Body’s R esponse to Infection
Natural History of Sepsis
The natural history of each infection can 
be conceptualized on an anatomic basis— 
that is, the body first attempts to localize
infection at the original site and then, with 
failure of localization, to confine the pro­
cess regionally. When regionalization fails, 
the blood stream is invaded and septicemia 
must be controlled with all homeostatic 
mechanisms.
At the site of injury, the body reacts with 
the classical inflammatory response to con­
tain invasion of bacteria. The usual result 
is control and resolution of the potential in­
fection. When infection becomes estab­
lished, the inflammatory response attempts 
to contain and localize the process. Sup­
puration and spontaneous drainage consti­
tute an obviously successful resolution of 
this response although suppuration is fre­
quently not required for local control.
Failure to localize then leads to cellulitis 
or some degree of lymphangitis, or both,
Fig. 2.—Determinants of infection in bum in­
jury. The common area secondary to abnormal 
environment and host defence mechanisms in­
dicates increase in probability of infection.
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and passage of the infecting organism 
through the lymphatic channels. This re­
sults in regional lymphadenopathy, second­
ary to local inflammation, and reactive 
edema effectively blocks lymph flow. Sup­
puration may result with regionalization of 
the infection. Cutaneous and pulmonary in­
fections are commonly controlled by these 
mechanisms. Streptococcal lymphangitis and 
lymphadenitis, mesenteric lymphadenopathy 
with acute, nonperforated appendicitis, and 
the Ghon complex in tuberculosis are com­
mon examples of the body’s attempt to re­
gionalize and contain a septic process. Al­
though this cannot occur in some regions 
(e.g. the pleural cavity and the brain) the 
concept is a useful one.
A few infections are not contained by 
these attempts at localization or regionaliza­
tion, and systemic invasion results. Simi­
larly, failure of localization may be followed 
by systemic sepsis, often as the result of 
specific bacterial properties; infections with 
Clostridium welchii are examples of this. 
When bacteremia does develop, the re­
sponses are many and various, including 
fever, chills and cardiovascular collapse. 
The reticuloendothelial system (RES), which 
attempts to clear the blood stream of bac­
teria by active phagocytosis, represents the 
final controlling mechanism against invasive 
sepsis. These lines of defence are an in­
tegral part of homeostasis just as the main­
tenance of cardiovascular stability is a 
homeostatic mechanism that prolongs life 
until the septic focus or process can be con­
trolled.
Environment: Local Factors
Local factors are mechanisms designed 
to prevent lodgement of infecting organisms 
(Table I). The skin and various mucous 
membranes throughout the body provide a 
mechanical barrier to bacterial invasion. In 
addition to presenting the purely mechan­
ical barrier, local factors have specialized 
biologic properties that facilitate control or 
eradication of bacteria. Biologic decon­
tamination may be mechanical or chemical 
or a function of the normal flora, which 
can restrain potential pathogens.
The skin, the body’s largest organ, pre­
sents a formidable mechanical barrier to the 
outside world. In addition, biologic decon­
tamination is the result of a number of 
biologic properties, which remove or con­
trol potential pathogens: mechanically, the 
skin sheds itself so that bacteria are re­
moved; chemically, its fatty acids can be 
bactericidal; and these fatty acids, together 
with the normal flora, biologically control 
the growth of potential pathogens. The tra­
cheobronchial cilia constitute a biologic 
mechanism to remove foreign materials and 
bacteria from the depths of the lungs. Tears 
have an antibacterial effect that helps to 
protect the eyes chemically and mechanic­
ally. The body’s normal flora can exert con­
siderable protection against pathogens, most 
commonly in the mouth and gastrointestinal 
tract. Oral candidiasis developing after the 
administration of penicillin lozenges and 
diarrhea or pseudomembranous ulcerative 
colitis complicating oral antibiotic therapy 
indicate the protective value of normal flora. 
The internal environment is protected from 
external pathogens by the barriers presented 
by skin and specialized membranes. When 
these barriers break down, infection is a 
potential problem because of failure to 
prevent the lodgement of bacteria.
The most obvious environmental altera­
tion of the skin is a thermal injury. Sepsis is 
common and is frequently the cause of 
death. Although other systemic sequels re­
sult from the burn injury, the loss of the 
skin envelope represents a failure of the 
initial barrier to infection. Much of the care, 
in cases of burns after resuscitation, is de­
signed to create, artificially, a protective 
barrier. Pig skin, artificial skin, and topical 
therapy are all aimed at excluding microbes. 
Success of these therapeutic methods is re­
flected by continued improvements with re­
spect to the morbidity and mortality from 
thermal injury.
Frequently these anatomic barriers are 
broken down by iatrogenic means, surgery 
being the most obvious example. The urinary 
catheter,4 the indwelling plastic intravenous 
cannula5 and the tracheostomy tube6 all 
bypass or interfere with normal anatomic 
barriers to change the environment and so 
make it more susceptible to invasive mi­
crobes.
Host Defence Components
To be effective, host defence requires the 
integrated and efficient function of a variety
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of component parts (Table I). The failure of 
any segment of the system can result in sep­
sis, as is apparent in the congenital im­
munologic deficiencies that affect single-cell 
systems and frequently result in persistent 
sepsis or lethal sepsis, or both.
Initially the inflammatory response acts 
as the basic delivery system. The classical 
signs of inflammation—rubor, dolor, tumor 
and calor— can be explained by examining 
the vascular, cellular and molecular com­
ponents of the inflammatory response.7, 8
The vascular changes are largely mediated 
through vasoactive amines, notably hista­
mine, serotonin and the kinins. These sub­
stances are coordinated to produce the 
vascular and endothelial changes that 
then allow delivery of the fluid and cellular 
components to the inflammatory response. 
The precise sequence of these components 
is not completely understood but the fol­
lowing is a synthesis of the process: The 
vascular response, initially vasoconstriction, 
occurs within minutes of the initial lesion 
and this is followed in 10 to 30 minutes by 
a persistent vasodilation. The overt cutane­
ous signs are the triple response of Lewis. 
Vasodilation is accompanied by changes in 
the vessel wall and subsequently by blood 
flow; stasis of blood is associated with in­
creased margination and adherence to the 
endothelial lining by polymorphonuclear 
leukocytes (PMNs). Endothelial changes al­
low diapedesis of the PMN into the inflam­
matory focus. The altered vessel wall and 
raised capillary pressure increase vascular 
permeability and this leads to delivery of 
plasma proteins— notably immunoglobulins, 
complement and fibrinogen. The breakdown 
of certain large protein molecules and the 
increased fluidity of the tissue ground sub­
stance also contribute to the “tumour” as­
sociated with inflammation.
The development of the cellular exudate 
parallels the formation of the fluid exudate; 
initially, the exudate consists almost ex­
clusively of PMNs.9 After the first 24 hours, 
the monocyte tends to replace the neutrophil 
as the predominant phagocytic cell. The 
monocyte, when activated, becomes an activ­
ated macrophage and, as such, is a more 
effective phagocyte. However, the macro­
phage also processes bacterial antigens or 
other antigens for delivery to the lympho­
cyte and production of specific antibody. As 
the inflammatory process develops, the 
lymphatics enlarge, in part secondary to 
local swelling, and lymphatic flow increases 
aiding delivery of antigen to the regional 
lymph nodes.
For purposes of this discussion, the in­
flammatory exudate is considered to be di­
rected against microbial invasion—primar­
ily, bacterial infection. The humoral opsonic 
component is composed of complement and 
immunoglobulins. The role of complement 
is multifaceted; in this context it facilitates 
immune adherence, bacterial cytolysis, PMN 
chemotaxis and phagocytosis. Immuno­
globulins— notably IgG and IgM— are, to­
gether with complement, involved in PMN 
bacterial phagocytosis. Bacterial cytolysis 
can be effected by complement and im­
munoglobulin but this has a small part in 
the control of invasive bacteria. The crucial 
role of complement is to attract PMNs to 
the bacteria and then, with IgG, to opsonize 
them for effective PMN phagocytosis. In 
the absence of complement or immuno­
globulins, phagocytosis is substantially de­
creased. Fibrinogen facilitates localization 
of the infection when it is able to form 
fibrin, as in abscesses, and it also supplies a 
matrix against which neutrophils can phago- 
cytize the bacteria that are not opsonized. 
Thus, the humoral and cellular components 
work together to control bacterial growth.
PMN activity constitutes the initial cellu­
lar response to a lesion. PMNs are actively 
phagocytic when delivered by means of 
diapedesis to the inflammatory focus. With 
ingestion, the bacterium is encased in a 
membrane-lined sac, the phagosome, which 
becomes a phagolysosome with degranula­
tion of the enzyme-rich contents of PMN 
lysosomes.10, 11 In these lysosomes are the 
many enzymatic and metabolic processes 
that result in bactericidal action.12 The 
PMN, a short-lived cell (half-life in circula­
tion, 6 hours), is constantly being produced 
by the bone marrow. Of the 2 to 3 billion 
PMNs in circulation, 50% are marginated 
on vessel walls or in closed capillary loops, 
and 200 to 300 billion PMNs are maintained 
in reserve in the bone marrow,9 so that large 
numbers of PMNs can be generated when re­
quired. The PMN is the initial bactericidal 
cell and is essential to the maintenance of
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intact host defence. 3 Cyclic variation of 
neutrophil function has been demonstrated 
in both normal persons and in burn and 
transplant patients. This cyclic variation of 
neutrophil bactericidal function is related 
to the development of sepsis in both nor­
mal and burn patients and to variations in 
quantitative burn wound cultures.3, 13 
Leukemic patients with profound neutro­
penia caused by chemotherapy have a very 
high incidence of septicemia that may not be 
controlled until either the neutropenia abates 
or granulocytes are transfused. The inability 
to contain sepsis associated with a lesion is 
a critical factor that then permits active 
microbial invasion.
The second line of phagocytic response is 
the monocyte. 8 14 At an area of inflamma­
tion the monocyte is activated to become 
an aggressive phagocytic and bactericidal 
cell, the macrophage, with a long half-life. 
Macrophage chemotaxis, active bacterial 
phagocytosis and intracellular killing re­
quire antibody and complement as do 
PMNs. After its ingestion and digestion, the 
microbial antigen is processed by the ma­
crophage and transported locally or region­
ally to lymphocytes for production of speci­
fic antibody. The cells that take part in this 
activity may be bone-marrow (B) lympho­
cytes or thymus-derived (T) lymphocytes. B 
cells produce specific antibodies and T cells 
produce specifically sensitized lymphocytes 
with a major role in protection against intra­
cellular parasites through the macrophage, 
which, when activated, becomes the effective 
microbicidal cell. 15
The macrophage is an effective “mop-up” 
cell that is able to ingest and dispose of cel­
lular debris, fibrin and other particulate mat­
ter. The PMN is primarily bactericidal and 
does not have the other extensive functions 
of the wandering macrophage. There are 
numerous tissue macrophages, probably also 
derived from monocytes, that are essential 
to the microbial host defence. These cells 
constitute the fixed RES made up of Kupffer 
cells (liver), littoral cells (spleen), microglial 
cells (brain), and pulmonary alveolar macro­
phages. There are macrophages in most 
other tissues and organ systems, but they 
are less numerous and are intensely supple­
mented by circulating cells when required. 
The fixed RES is primarily a blood filter and
is the clearance mechanism for particulate 
matter as well as any microbes that may have 
entered the circulation. The Kupffer cells 
form the largest mass of the RES and are 
instrumental in control of systemic as well 
as transient portal vein bacteremia. The al­
veolar macrophage is important in con­
trolling pulmonary sepsis and clearing any 
particulate matter that is not removed by 
the liver. Therefore, the lung may become a 
target organ in sepsis and other comparable 
low-flow states. The macrophage also has 
a role in cellular immunity.
In this discussion, cell-mediated immunity 
(CMI) will be considered to be limited to 
intracellular parasites, most notably Myco­
bacterium tuberculosis and Listeria monocy­
togenes, 15 and fungal infections (Table II). 
CMI is also of importance in viral infec­
tions, tumour and transplant immunity, and 
autoimmune disease. Delayed hypersen­
sitivity is mediated through CMI, and failure 
to respond appropriately can reflect an al­
teration in immune response. The antimi­
crobial action of CMI is mediated through 
a complex system of recognition and cell 
activation involving different cells and num­
erous humoral mediators. In simplified 
terms, the cell-mediated antimicrobial sys­
tem is based on recognition of antigen by T 
lymphocytes and subsequent macrophage 
attraction and stimulation. If the body has 
not previously been infected with the spe­
cific organism, time is required before sen­
sitized lymphocytes are produced. In this 
situation the reaction will work somewhat 
in reverse; that is, the bacterial antigen will 
be processed by macrophages and delivered 
to lymphocytes for production of specifically 
sensitized T cells, which then will be effect­
ive at the site of infection.
When the host has previously been in­
fected with a particular microbe, specific T 
cells are attracted to the focus of infection, 
where they are more specifically activated to 
produce lymphokines, 16  a family of soluble 
humoral mediators, some of which can af­
fect macrophages. The lymphokines of spe­
cific interest are migration inhibition factor 
(M IF) and macrophage activation factor 
(MAF). MIF attracts macrophages to the 
infective focus and retains them in the area 
and MAF converts them into activated cells 
capable of effective antibacterial function.
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The process and mechanism of intracellular 
killing is similar to those typical of PMNs. 
Failure of T-cell function or congenital ab­
sence of T cells results in failure to mount 
an effective antimicrobial response against 
intracellular parasites.17
The three compartments of host defence 
—humoral, phagocytic and CMI— each are 
most effective against certain organisms or 
classes of organisms (Table II). The host has 
a complex defence system; usually two of 
the three compartments are active against 
invading microbes though one may be pre­
dominant. For example, in the absence of 
specific antibody, the pneumococcus is not 
phagocytized by PMNs, but, once present, 
phagocytosis and intracellular killing pro­
ceed rapidly; the key to this defence is the 
specific antibody although control of the 
actual infection is a two-compartment effort.
Clinical A spect of Defects in
Host D efence
The defects in host defence of particular 
interest to the surgeon are those that develop 
secondary to physiologic status, drug therapy 
or disease state. The first immune defect re­
ported was agammaglobulinemia.18 Many 
other congenital abnormalities of PNM, 
lymphocyte and thymic function have been 
identified since, incorporating all aspects of
Vol. i s
host defence.19 But although patients with 
such defects persistently manifest serious 
septic complications, they do not commonly 
present with surgical problems.
Acquired defects of host defence (Table 
III) are different, for many of them are 
caused by, or related to, surgical disease or 
secondary to surgical complications.-0 Drugs 
may have a major role in the alteration of 
host defence. Acquired defects primarily 
affect patients receiving cancer chemother­
apy, steroids or immunosuppressive agents. 
Age, sepsis, some antibiotics, radiation, col­
chicine and phenylbutazone all can depress 
host resistance.3' 19-28
The burn injury presents the best example 
of wide-ranging alteration of systemic 
host defence secondary to the basic 
illness.3- 21' 22 within days after a severe 
burn injury of at least 30%, alterations in 
neutrophil bactericidal function become ap­
parent. Qualitative and quantitative bac- 
teriologic findings with respect to the burn 
wound and severe sepsis are related to ab­
normal neutrophil bactericidal function,3' 22 
and severe sepsis can be the cause as’ well 
as the result of abnormal neutrophil func­
tion.28 In addition, there are defects in cel­
lular immunity, reflected by the inability to 
reject skin grafts and anergic responses to 
recall antigens and alterations in alternate
TABLE II. E fficacy of Three Compartments of H ost Defence in Countering Various
tious Organisms (Greatly Simplified) Infec-
Humoral
Bacteria
Pneumococcus
Streptococcus
Hemophilus
Meningococcus
Pseudomonas
Toxins
Diphtheria
Tetanus
Viruses
Poliomyelitis
Hepatitis
Rubella
Others
Component effective against infectious agent
Cell-mediated Phagocytic
Bacteria
Mycobacteria
Listeria
Brucella
Salmonella
Staphylococcus*
Fungi
Candida spp.* 
Aspergillus 
Histoplasma 
Mucor
Bacteria
Staphylococcus*
Klebsiella
Aerobacter
Serratia
Proteus
Probably most other enteric 
and anaerobic bacteria 
Fungi
Candida spp.*
Viruses
Vaccinia
Cytomegalic inclusion
disease
Most others
Parasites
_____________________________Pneumocystis carinii
COTfpitment'm^y^mt'be possible!1*61^  ** ^  COmpartmenteoThost defenceTselectmg the predominant
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pathway to complement activation.21 Anti­
body response is adequate, though it is not 
as striking as in healthy persons. Antibody 
production is sufficient in response to hep- 
tavalent Pseudomonas vaccine to provide 
significant protection against invasive sepsis 
resulting from Pseudomonas spp.29 The im­
munologic alterations in the burn injury do 
not return to normal until the burn wound 
is completely covered. Although the burn 
patient is unusual in the extent and severity 
of injury as well as the broad immunologic 
changes secondary to that injury, it is be­
coming apparent that severe sepsis in sur­
gical patients, major operative procedures 
and nutritional defects can lead to altera­
tions in basic immunologic homeostasis that 
are a threat to life.
The burn injury also produces a definite 
alteration in local protective factors; the 
environment has been clearly changed. Not 
only has the protective barrier been changed 
and its biologic properties destroyed but 
also in its place is a superb culture medium. 
As Fig. 2 suggests, the environmental and 
HDM sets are proportionally larger with no 
change in the bacterial determinant. The 
resultant common area is significant and re­
flects the increased probability of sepsis in 
the burn injury. As the treatment of burns 
has progressed, much attention has been 
directed to control of burn wound flora 
and the burn wound itself. The bacteria in 
the wound are largely being controlled with 
use of antimicrobial topical therapy. Modern
therapy incorporates a better understanding 
of, and care for, the burn wound itself, pre­
senting a less attractive environment for sep­
sis. The remaining obvious objective is in 
the understanding and role of immunologic 
mechanisms in the development of infec­
tions in burns. Recent work indicates that 
these are important.3- 22- 30 The therapeutic 
goal is to reduce the size of the respective 
environmental and HDM sets thereby re­
ducing the area of intersection and the 
probability of sepsis.
Laboratory Evaluation of
Host Defence
The concept of the interaction of HDM 
and microbes as determinants of sepsis is 
very useful. However, at the practical level, 
it is important to be able to define the de­
fects that are or may become amenable to 
therapy. Many of these investigations can 
be conducted in any general hospital al­
though some are available only in large- 
centres or, indeed, in specialized research 
laboratories. Table IV outlines the ap­
proaches that might be available at these 
various institutions; they are arranged ap­
proximately in the order of a reasonable 
investigation.
Before a vast array of laboratory examin­
ations is requested, a careful clinical assess­
ment is made to exclude continuing sepsis 
on the basis of, for example, an overlooked 
lesion, a foreign body, or undrained abscess. 
Additionally, a history concerning past in-
TABLE III.—Acquired Defects of Host Defence
Defect
Physiology
Perfusion...................
Age..............................
Malnutrition.............
Disease-related
Diabetes....................
Burns..........................
Cancer........................
Lymphoproliferative
Sepsis..........................
Trauma......................
Therapy
Steroid...............
Chemotherapeutic.. 
Immunosuppressive. 
Radiation..................
Host defence mechanism
Inflammation Humoral Phagocytic Cell-mediated
+ +± + ± (? ) +
+
± + +
± ± +
+ + +
+ + +
± ± ±
+ ± ++ +
± +
±  (Local) +
+  =  clear defect; ±  =  relative defect.
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fections, susceptibility to sepsis and ease of 
therapy together with an assessment of a 
patient’s ability to localize infection, to de­
velop lymphadenopathy and to mount an 
apparent inflammatory response in light of 
age, nutrition, underlying disease and drug 
therapy are all essential before one orders 
thousands of dollars’ worth of laboratory 
studies.
Initial studies comprise a total leukocyte 
count with differential and a morphologic 
assessment of PMNs and lymphocytes. The 
appropriate response to sepsis can be as­
sessed and the question of whether neutro­
penia or lymphocytopenia might be a prob­
lem can be considered. The inflammatory re­
sponse can be estimated from the clinical 
evaluation, use of a skin window and deter­
mination of humoral factors by means of 
immupoelectrophoresis or quantitation of 
the specific immunoglobulins IgG, IgA and 
IgM. Skin testing with the antigens listed in 
Table IV, to which 95% of persons will re­
spond with a delayed hypersensitivity reac­
tion, will indicate anergy.31- 32 Cellular im­
munity may further be assessed from the 
patient’s ability to reject a skin graft.
Neutrophil bactericidal function, mobility 
and response to chemotaxis can be reason­
ably evaluated.3' 2 0 , 2 8 Nitroblue-tetrazo- 
lium reduction (NBT)22’ 33 can be evalu­
ated qualitatively or quantitatively. Dinitro- 
chlorbenzene (DNCB) sensitization requires 
some skill and experience in application and 
assessment and indicates a particular pa­
tient’s ability to respond to a specific anti­
gen with a cell-mediated response.24 Values 
of some components of complement are 
readily determined, though evaluation of 
the complete cascade and the alternative 
pathway are more specialized. Mixed lym­
phocyte culture and phytohemagglutinin 
(PHA) stimulation indicate the ability of 
lymphocytes to respond to appropriate stim­
uli.
It is possible to evaluate effectively most 
aspects of the immune response. Areas of 
difficulties or expense are RES clearance, 
monocyte function and accurate assessment 
of monocyte: macrophage lymphocyte inter­
action. In microbial infection—whether this 
is viral, fungal, or bacterial— the host is 
generally obliged to destroy the parasite to 
control infection effectively. Evaluation of 
the effector cell mechanism and the method 
of activation become important and are not 
yet available for clinical studies. Thus, ultim­
ately the interaction of humoral factors, pha­
gocytic cells and lymphocytes become an 
important assessment.
Immunotherapy
At present, immunotherapy is usually con­
sidered to be an anticancer form of therapy. 
However, this form of therapy has been used 
in bacterial infections for 60 years. Passive 
immunotherapy was started when Behring34 
successfully introduced diphtheria antitoxin 
in 1913. Specific antitoxins in other forms 
of bacterial sepsis have had considerable 
use, a recent example being human hyper­
immune globulin against tetanus. Antisera
TABLE IV.—Laboratory E valuation of Host D efence Conducted According to Sophistication
of M edical Facility
Laboratory testing according to sophistication of medical facility
Host defence mechanism Community hospital Referral hospital Specialized laboratory
Inflammation Skin window
Humoral Immunoelectrophoresis 
Immunoglobulin: IgG, 
IgA, IgM
Complement Alternate pathway 
Antibody response to 
specific antigens
Phagocytic Neutrophils, monocytes: PM N : bactericidal Monocytes, macrophages:
count, morphology function, motility, 
chemotaxis
bactericidal function
NBT
Skin window
Quantitative NBT RES clearance 
M IF
Cell-mediated Lymphocytes: count, 
morphology
Skin tests: PPD. varidase, 
mumps, trichophyton, 
Candida spp.
DNCB sensitization 
Skin graft rejection
Mixed lymphocyte culture 
PHA stimulation
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have also been used, the best known being 
the antiserum against pneumococcal pneu­
monia. Pseudomonas hyperimmune globulin 
is a polyvalent hyperimmune serum that has 
proved effective in the management of in­
vasive sepsis of the burn wound and septi­
cemia resulting from infection with Pseudo­
monas spp. 29 Active humoral immuno­
therapy with vaccines has been effective in 
prevention of tetanus and more recently the 
use of Pseudomonas heptavalent vaccine has 
proved helpful in thermal injuries. 29 These 
antitoxins, antisera and vaccines are directed 
against specific bacterial or viral disease. It 
is apparent that the pathogen must be sus­
ceptible to a humoral approach either by 
neutralization of toxins or opsonization of 
microbes for phagocytosis. Nonspecific use 
of gamma globulin is effective in patients 
with hypogammaglobulinemia or agamma­
globulinemia.
Comparable techniques to support phago­
cyte function are not yet available. Granu­
locyte transfusions are helpful in the man­
agement of severe neutropenia, 35 usually 
the result of bone marrow suppression. 
Large volumes of viable cells are required. 
But because nonspecific stimulation of ab­
normal neutrophil function has not so far 
been achieved it is not yet possible to help 
patients with PMNs that are normal in num­
ber although not functioning adequately. In 
some cases of burns, enteric hyperalimenta­
tion has alleviated severe abnormalities of 
PMN function. 3 0  The specific factors are 
not yet clear. Nutrition can be considered 
a form of immunotherapy, albeit nonspecific. 
In animals, the RES can be stimulated with 
a variety of nonspecific agents or colloidal 
suspensions; however, such measures (e.g. 
endotoxin) are not suitable for human use.
The critical role attributed to CMI in the 
control of neoplasia has stimulated a great 
deal of research in this field, much of which 
will provide insight into problems of sur­
gical sepsis. The initial steps were taken in 
attempts to control disease in children with 
congenital defects of CMI; the approach re­
volved around cellular reconstitution through 
transplantation of thymic tissue, bone mar­
row or fetal hematopoietic tissue. Lympho- 
cytotherapy has also been used in these 
situations. There are many difficulties with 
these forms of therapy, not least of which is
obtaining material for transplantation; how­
ever, more serious is the graft-versus-host 
reaction, which is common and can be life- 
threatening. These modalities are primarily 
applied to the treatment of congenital ab­
normalities or to the management of a pa­
tient after bone marrow ablation secondary 
to drugs or radiation. Nevertheless, it is 
possible that identification of specific ac­
quired defects of CMI will make reconstitu­
tion or cellular support possible for a finite 
period.
Nonspecific stimulants of CMI demon­
strate some interesting results in manage­
ment of both neoplasia and infection. BCG 
vaccine and levamisole hydrochloride are at 
present undergoing large-scale trials in Can­
ada and the United States as adjunctive ther­
apy in cases of melanoma, sarcoma, cancer 
of the lung and gastrointestinal tract. As yet 
there seems to be no application of these 
agents to infection. However, transfer fac­
tor, 36  a soluble lymphokine that can be 
produced in vitro, has been useful in the 
treatment of chronic mucocutaneous candi­
diasis and, more recently, of leprosy. 3 7 These 
are not surgical illnesses; however, it is be­
coming increasingly apparent that acquired 
defects in CMI in surgical patients develop 
under situations of protracted serious illness 
and sustained sepsis. Law, Dudrick and 
Abdou, 24 have recently demonstrated that 
prolonged hypoalimentation leading to pro­
tein calorie malnutrition can produce de­
fects in CMI that can be corrected with 
hyperalimentation. The specific abnormal­
ities that were corrected were the ability to 
produce antibody response to DNCB, 
recovery from an anergic or relatively an­
ergic state and a relative improvement in 
lymphocyte response to PHA. It is to be 
hoped that the time when general support of 
the various components of host defence can 
be accomplished is not too far away.
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RESULTS OF MINOR FOOT AMPUTATIONS FOR ISCHEMIA OF 
THE LOWER EXTREMITY IN DIABETICS AND NONDIABETICS*
GORDON A. HUNTER, MB, FRCS(Eng), FRCS[C]
Summary: Results of 208 minor amputations 
were analyzed in 179 patients who had no foot 
pulses. Wound healing was assessed at 3 months 
in relation to diabetes and previous vascular 
surgery. The results suggest that simple removal 
of the toe or toes is not advisable unless the 
blood supply to the foot can be improved by 
vascular reconstruction or sympathectomy, or 
both. Transmetatarsal amputation should be con- 
|  sidered more often! as a conservative amputation 
k for gangrene of the toes. The absence of a 
I palpable posterior tibial pulse is a contraindica- 
en; tion to the Syme's amputation.
relf Resume: Nous analysons les resultats de 208 
amputations mineures pratiquees chez 179 ma- 
lades qui n'avaient pas de pouls aux arteres 
pedieuses. Au bout de 3 mois, nous avons 
evalue la cicatrisation de la plaie, en tenant 
compte de la presence de diabete et d'inter- 
ventions vasculaires anterieures. II appert de ces 
resultats que la simple ablation d'un orteil ou de 
plusieurs orteils n'est pas recommandee a moins 
que la circulation dans le pied puisse etre ame- 
lioree par reconstruction vasculaire ou par 
sympathectomie, ou par les deux methodes. Une 
amputation transmetatarsienne devrait etre envi- 
sagee plus souvent comme mesure conservatoire 
pour la gangrene des orteils. L'absence d'un 
pouls tibial posterieur palpable est une contre- 
indication formelle a I'amputation de Syme.
Gangrene of one or more toes is a late pre­
senting feature of patients with peripheral 
vascular disease. In view of the high mor­
tality rate of thigh amputations,1 and the 
fact that elderly patients find it difficult to 
master the use of a prosthesis, recent re­
ports2’ 8 have stressed the value of below- 
knee amputations.
There is little information in the recent 
literature about the results of minor ampu­
tations of the foot (toe or toes, transmeta­
tarsal and Syme’s)4 19 in patients with peri­
pheral vascular disease with or without dia­
betes. Table I summarizes the results re­
corded in the literature. In addition, Burgess
*From the division of orthopedic surgery, depart­
ment of surgery, St. Michael’s Hospital, Univer­
sity of Toronto, Toronto, Ont.
Reprint requests to: Dr. G. A. Hunter, Division 
of Orthopedic Surgery, St. Michael’s Hospital, 30 
Bond St., Toronto, Ont. M5B 1W8.
(personal communication, 1973) estimated 
that in less than 5% of patients with gan­
grene of the toes due to arteriosclerosis will 
healing occur after simple toe removal only. 
Kelly (personal communication, 1973) put 
the success rate following minor amputation 
of toes at between 40 and 50%. Also of in­
terest is the text by Gillis,20 who states that 
the Toronto school believed Syme’s ampu­
tation to be an excellent operation, based on 
the work of Dale11 and Harris.21 Dale, 
however, suggested that he often achieved 
success in the patient who already had pal-r 
pable pulses in the foot. Harris21 stressed 
the importance of avoiding division of the 
posterior tibial artery for fear that the flap 
would slough.
These conflicting reports stimulated a 
retrospective review of the results of re­
moval of toes and Syme’s amputations in 
peripheral vascular disease from the Toronto 
teaching hospitals during a 10-year period, 
1964 to 1974. It became possible to assess 
the results of transmetatarsal amputation 
and to compare them with the results from 
the available literature.
Criteria for Selection and
Details of Operative Procedures
My criteria for selection in this review 
were as follows:
1. Peripheral vascular disease, indicated 
by the lack of palpable foot pulses (dor­
salis pedis and posterior tibial arteries). 
Patients with Buerger’s disease were ex­
cluded because of the confusion about the 
true nature of this disease.
2. Necrosis or gangrene of one or more 
toes.
3. Classification of operation as removal 
of toe or toes, or as transmetatarsal or 
Syme’s amputation.
In addition, the patient may or may not 
have been diabetic, and note was made as 
to whether the patient had had recent vas­
cular surgery or sympathectomy, or both, 
within the month preceding the minor oper­
ation.
With respect to the operative results, 
delay in wound healing implied continued
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failure of the wound to heal 3 months after 
the initial operation. If subsequent revision 
was necessary 1 or 2 years later— in my 
experience this is rare— the initial operation 
was still considered a success.
Sufficient information was available on 
208 minor amputations in 179 patients. Five 
patients had bilateral, minor foot amputa­
tions. The operations are enumerated in 
Table II.
Wound healing was reported as a success 
or failure 3 months after the initial oper­
ation.
Data relating to wound healing at 3 
months are presented in Tables II and III. 
Table III gives the success rate in terms of 
wound healing for each level of amputation.
Healing in Relation to Diabetes
Long-standing diabetes is commonly as­
sociated with a general disorder of small 
blood vessels, seen as an abnormal thicken­
ing of the basement membrane of the capil­
laries throughout the body.22
In the assessment of the “diabetic foot” 
(Fig. 1) these small-vessel changes have
TABLE I.—Summary of R esults of M inor Amputations of the Foot Recorded in the Literature
Author{s)
No. of 
operations
No. (and %) 
of wounds healed Comment
Amputation of Toe(s)
Kelly and Janes9...................... 49 19 (39) Diabetics and nondiabetics; all 
had arteriosclerosis
Schlitt and Serlin10.................. 21 15 (71) Diabetics and nondiabetics; all 
had peripheral vascular disease
Baddeley and Fulford13........... 74 30 (41) All were diabetics with arterio­
sclerosis
Bradham and Smoak14............ 15 8 (53) Diabetics and nondiabetics; most 
had no foot pulses
Warren and Kihn15.................. 10 4 (40) Diabetics and nondiabetics; 
details of foot pulses not given
Hunter (present series)............
McKittrick, McKittrick and
128 42 (33) 
Transmetatarsal Amputation
Diabetics and nondiabetics; no 
foot pulses
Risley4......................................... 145 94 (65) No mention of state of foot 
pulses
Warren et at5.............................. 43 27 (63) —
Pedersen and Day7................... 33 25 (76) Majority were diabetics; all had 
peripheral vascular disease
Carney and Goldowsky8.......... 10 2 (20) —
Schlitt and Serlin10.................. 9 3 (33) Diabetics and nondiabetics; all 
had peripheral vascular disease
Wheelock12................................. 336 213 (63) All were diabetics; healed at 2 
years; no mention of foot pulses
Baddeley and Fulford13........... 4 2 (50) —
Bradham and Smoak14............ 12 4 (33) Diabetics and nondiabetics; most 
had no foot pulses
Warren and Kihn15.................. 32 16 (50) Diabetics and nondiabetics; 
details of foot pulses not given
Schwindt, Lulloff and Rogers18 88 55 (63) Diabetics and nondiabetics; some 
had foot pulses
Hunter (present series)............ 26 12 (46) 
Syme’s Amputation
Diabetics and nondiabetics; no 
foot pulses
Warren et ald .............................. 6 5 (83) Included 3 diabetics; none had 
foot pulses
Schlitt and Serlin10.................. 1 0 ( 0) —
Dale11.......................................... 13 5 (38) Other good results had foot 
pulses, or surgery was performed 
for old trauma
Baddeley and Fulford13........... 7 5 (71) —
Rosenman16............................... 13 9 (69) Included 6 diabetics; no foot 
pulses
Sarmiento17................................ 38 19 (50) Majority were diabetics; all had 
peripheral vascular disease
Hunter (present series)............ 54 15 (28) Diabetics and nondiabetics; no 
foot pulses
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probably been emphasized too much. In 
diabetic patients requiring an amputation, 
loss of palpable foot pulses is common, and 
histologic studies23- 24 indicate that the ar­
terial lesion in the limb amputated for ar­
teriosclerosis obliterans without diabetes 
is not pathologically different from the ar­
terial lesion in the limb amputated for arte­
riosclerosis obliterans with associated dia­
betes.
The results of this study (Table III) sug­
gest that diabetics with ischemic feet (i.e. an 
absence of foot pulses) should not be treated 
any differently from nondiabetics, when the 
level of amputation is being considered.
Healing in Relation to Previous
Vascular Surgery
This study also suggests that the results 
of removal of one or more toes were en­
hanced if vascular reconstruction with or 
without sympathectomy had been performed 
during the preceding month (Table II). This 
improvement in results, however, did not
NEUROPATHY
LARGE-VESSEL
DISEASE
SMALI>VESSEL
DISEASE
Muscle atrophy 
Impaired sensation
-f- infection
GANGRENE -
Ulceration 
, Foot deformity
+ trauma 
f- infection
Fig. 1.—Interrelationship of diabetes and is­
chemia in gangrene of toe.
affect patients who underwent amputation 
at the transmetatarsal level or Syme’s am­
putation.
On physiologic grounds, sympathectomy 
may be expected to improve the skin cir­
culation for the first 48 hours, but there is 
no evidence to suggest that it improves 
muscle blood flow.25
Each patient therefore should be assessed 
for possible vascular reconstruction before 
minor amputation is performed.
C o n c l u s io n s
This survey justifies the following state­
ments with respect to assessment of the level 
for minor amputations in patients with 
ischemic feet whose toes are necrotic or 
gangrenous:
1. Simple removal of the toe or toes is 
not recommended unless vascular surgery is 
successful in improving the circulation to 
the foot before amputation.
2. Transmetatarsal amputation should be 
more seriously considered as a suitable con­
servative procedure. Contraindications to 
this procedure include gangrene of the dor­
sal or plantar aspects of the foot and severe 
rest pain in the foot.4
3. There is little place for Syme’s ampu­
tation in a pulseless foot, an observation 
confirmed by Shelswell26 and Sarmiento.17
My thanks are due to the medical records de­
partments o f the teaching hospitals in Toronto. I 
am indebted to the department of medical arts at 
St. Michael’s Hospital for the illustration.
TABLE II.—Wound H ealing in Relation to 
Level of Amputation
Level of 
amputation
No. of 
operations
No. of wounds 
{and %) healed 
at 3 mo
Toe(s) 128 42 (33)
Transmetatarsal 26 12 (46)
Ankle (Syme’s) 54 15 (28)
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SQUAMOUS CELL CARCINOMAS OF THE SKIN OF THE PINNA*
NORMAN J. SHIFFMAN, MD
Summary: Among 52 patients with squamous 
cell carcinoma of the skin of the pinna seen 
consecutively between 1952 and 1973, a single 
course of treatment failed to control the disease 
in 10 (19% ). This failure rate is higher than that 
usually reported for squamous cell carcinomas 
of the skin in general (2 to 6 % ), and appears 
to be in conflict with the belief that squamous 
cell carcinomas of the skin of the pinna rarely 
metastasize. It appears that other factors than 
neglect are responsible for this discrepancy. In 
this series it was not possible to judge the 
relative efficacy of one mode of treatment over 
another.
Resume: Parmi les 52 malades atteints d'epi- 
theliome de la peau du pavilion auriculaire 
que nous avons vus consecutivement de 1952 
a 1973, une seule seance therapeutique n'a 
pas permis de guerir la maladie chez 10 malades 
(soit 19% du total). Ce pourcentage d'echecs 
est plus eleve que celui qu'on a signale dans les 
cas d'epitheliome de la peau en general (2 a 6% ) 
et il sembie etre en disaccord avec la croyance 
que la tumeur du pavilion auriculaire n'est 
que rarement I'objet du metastases. D'autres 
facteurs que la negligence jouent un role dans 
cette divergence. Dans notre groupe de ma­
lades, nous n'avons pu juger I'efficacite rela­
tive d'un traitement sur un autre.
A m o n g  white persons living in temperate 
climatic zones, squamous cell carcinoma 
of the skin accounts for approximately 20% 
of all skin cancers. Although the malignant 
potential of such cancers is somewhat greater 
than that of basal cell carcinoma, they are 
generally treated successfully by electro­
desiccation and curettage, surgery and radio­
therapy.1 Their malignant potential is in­
dicated in three studies: Williamson and 
Jackson2 reported 108 cases of squamous 
cell carcinoma of the skin, of which 6 
(5.5%) showed evidence of metastases; 
Lund3 found that 4 of 780 (0.5%) such 
lesions metastasized; and Epstein and col­
leagues4 reported a series of 7000 lesions, 
of which 2% manifested evidence of metas­
tases at the time of diagnosis.
*From the Civic Hospital division, Ottawa clinic, 
Ontario Cancer Foundation, Ottawa, Ont.
Reprint requests to: Dr. N. J. Shiftman, Suite 508, 
1081 Carling Ave., Ottawa, Ont. K1Y 4G2.
The incidence of metastases from squa­
mous cell carcinomas of the skin of the 
pinna appears to be much higher than the 
incidence reported in these studies.5 The 
purpose of this article is to determine the 
incidence of recurrence or metastases, or 
both, from squamous cell carcinomas of the 
pinna and to determine whether this inci­
dence is related to the initial treatment of 
these lesions.
P a t ie n t s  a n d  M e t h o d s
The material for this study is derived 
from the records of 52 patients with squa­
mous cell carcinoma of the skin of the pinna 
seen consecutively between 1952 and 1973 
inclusive, at the Ottawa Civic Hospital divi­
sion, Ottawa clinic, Ontario Cancer Founda­
tion. The skin tumour clinic at the Ottawa 
Civic Hospital is a general referral and multi­
disciplinary clinic, the members of which in­
clude a radiotherapist, a plastic surgeon, a 
dermatologist and a pathologist. The diag­
nosis in each patient was made by biopsy, 
and each patient was managed and followed 
under the direction of the clinic. The major­
ity of patients referred to this clinic are of 
Irish, Scottish or French descent and live 
in the Ottawa valley; a large number live in 
rural areas. There were 50 men and 2 
women; their mean age was 73 years (range, 
28 to 96 years).
Fig. 1.—Distribution of squamous cell carcino­
ma of pinna in 52 patients.
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R esults
Distribution and Pathologic Features
The site of the lesion was the left pinna 
in 30 patients and the right in 22. Of the 
52 lesions, the most common site of occur­
rence was on the helix (27 lesions); the 
medial aspect of the pinna (helix not in­
cluded) was the site of 11, the antihelix of 6, 
the triangular fossa of 3, the concha of 3 
and the lobule was the site of 2 lesions (Fig. 
1). The greatest diameter of the lesion was 
less than 2 cm in 31 instances, 2 to 4 cm in 
15, greater than 4 cm in 2 and not recorded 
in 4. With respect to duration, 22 lesions had 
been present for less than 6 months at the 
time of diagnosis, 7 for between 6 months 
and 1 year, 10 for between 1 and 3 years, 
and 10 lesions had been noted for longer 
than 3 years; in the other 3 cases the dura­
tion of the lesion was not known.
Invasion of the cartilage at the time of 
diagnosis had occurred in 11 lesions. At this 
time none showed any evidence of skin, 
lymph-node or distant metastases.
Treatment and Outcome
The initial therapy was surgical excision 
in 31 patients, radiotherapy in 2, surgery 
and radiotherapy in 4, and electrodesicca­
tion and curettage or surgery and curettage 
in 15. The mode of treatment with respect 
to size of lesion is indicated in Table I. The 
period of follow-up was less than 1 year in 
15 patients, from 1 to 3 years in 11 and 
for more than 3 years in 26.
In 10 patients, all men, the initial treat­
ment failed to control the disease. Details 
of the lesions, the treatment and the out­
come are summarized in Table II. Five of 
the patients were initially treated surgically,
four had been treated by surgery and curet­
tage or electrodesiccation and curettage, and 
one had been treated with radiotherapy. In 
three of the patients, there was definite 
evidence of destruction of cartilage at the 
time of initial treatment. In 3 of these 10 
patients there was local recurrence; in 1, 
lymph-node metastases; in 1, skin meta­
stases; in 2, local recurrence and lymph-node 
metastases; in 1, local recurrence, lymph- 
node and distant metastases; in 1, local 
recurrence and distant metastases; and in 
the remaining 1, lymph-node and distant 
metastases. The site of 5 of the 10 lesions 
was the helix and of the other 5, the medial 
aspect of the ear. With respect to greatest 
diameter of the lesion at the time of diag­
nosis, two measured less than 2 cm, seven 
had been between 2 and 4 cm and one had 
measured more than 4 cm. Five of the le­
sions had been present for less than 1 year 
at the time of diagnosis and three had been 
present for more than 3 years; the duration 
of the other two lesions before diagnosis was 
not known.
Of the 10 patients in whom the initial 
treatment failed to control the disease, 4 
died as a direct result of their neoplasm, 
4 died of unrelated causes with no evidence 
of neoplastic disease after a second treat­
ment, and 1 died of unrelated causes but 
had evidence of local recurrence after having 
refused a second treatment; the remaining 
patient was lost to follow-up after having 
received a second course of treatment.
Discussion
Since the publication of the report by 
Broders in 1971,6 many authors7 17 have 
agreed that squamous cell carcinomas of 
the skin of the pinna have a worse prognosis 
than squamous cell carcinomas elsewhere on
TABLE I.—-Mode of Initial T herapy with R espect to Size of Lesion
Greatest
diameter
(cm)
Initial therapy
Surgery Radiotherapy
Surgery and 
radiotherapy
Electrodesiccation 
or surgery with curettage Total
2 18 (1)* 0 1 12 (1) 31 (2)
2 — 4 9 (2) 1 CD 2 3 (3) 15 (6)
4 2 (2) 0 0 0 2 (2)
Not recorded 2 1 1 0 4
Total 31 2 4 15 52
*Numbers in parentheses refer to cases of failure to control disease.
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T able II.— D etails of 10 Cases of Failure of Control of D isease
Initial lesion Time
------------------------------------------------------------------------------------------ — ------------------------ I nit
Age, Duration Trml
Status Sex Size before Mode of to
Case post-treatment (yr) (cm) Location treatment treatment Recur Comment
►
V
v
Local recurrence 88, M 3 Medial 4 mo Electrodesiccation, 2 Ear excised; died of
surface curettage heart failure yr
later
Local recurrence 89, M 4 Medial Unknown Surgical excision 2 Refused further treat­
surface ment; died of heart
failure 2 mo later
3 Local recurrence 96, M 1.8 Helix 10 yr Surgical excision 8 Widely excised; died 
of pneumonia 7 mo 
later
4
4 Skin metastases 84, M 2.3 Helix Unknown Surgical excision 
to adjacent 
scalp
18 Retreated with super­
ficial x-ray; lost to 
follow-up
5 Lymph-node 
metastases
76, M 4.5 Medial 5 mo Surgical excision 
surface
9 Radical neck dissec­
tion; died of pneumo­
nia 9 mo later with 
no evidence of recur­
rence
~V
6 Local recur- 96, M 1 
rence, lymph- 
node metastases
Medial 10 yr Surgery, curettage 7 Wedge excision and 
surface lymph-node biopsy;
died of heart failure 1 
mo later
7 Local recur- 81, M 2.5 Helix 6 mo Radiotherapy 
rence, lymph- 
node metastases
12 Refused further treat­
ment; died 1 mo later 
of carcinomatosis
8 Local recur- 88, M 
rence, lymph- 
node and distant 
metastases
2.5 Medial 3 mo 
surface
Electrodesiccation, 6 
curettage
Explosively malignant 
despite therapy; died 
1 yr later of carcino­
matosis
Local recur- 65, M 3 Helix 6 mo Electrodesiccation, 6 Metastasized to brain;
rence, distant curettage died 3 yr later of
metastases carcinomatosis
i 10 Lymph-node 72, M 3 Helix 
and distant me­
tastases
10 yr Surgical excision 9 Widespread metas­
tases; died 2 yr later 
of carcinomatosis
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the body surface. A notable contradictory 
opinion is that of Ash, Beck and Wilkes,18 
who observed that these tumours rarely me­
tastasize. However, review of the literature 
discloses many problems. Authors of all of 
the reports, save three, have grouped 
squamous and basal cell carcinomas to­
gether, even though it is well known that 
they behave differently. Also, most of these 
authors considered all cancers of the ex­
ternal ear together, regardless of whether 
they originated in the external canal or on 
the skin of the pinna. For the purposes of 
this discussion, only those reports that made 
it possible to ascertain, with some certainty, 
which lesions were actually squamous cell 
carcinomas arising on the skin of the pinna 
will be considered.
Mohs10 described 107 cancers of the 
pinna, of which 52 were squamous cell car­
cinomas. All of these were treated by chemo- 
surgery. Of 31 patients who were followed 
for between 6 months and 3 years, 23 
(74.2%) were cured. However, 10 patients 
died of their cancer within 6 months of 
diagnosis and 23 (44.2,%) died as a result 
of their cancer within 5 years.
Huriez, Lebeurre and Leperre5 reviewed 
75 cases of squamous cell carcinoma of the 
skin of the pinna, of which 71 were treated. 
Of the 62 patients for whom there was ade­
quate follow-up, 50 (80.6%) were cured 
and 12 (19.4%) had recurrence; 8 (12.9%) 
died of their cancer.
Blake and Wilson19 reported a series of 
81 squamous cell carcinomas of the skin of 
the pinna. Of the 71 lesions treated surgical­
ly, 15 recurred, and of 8 lesions treated with 
radiotherapy there was evidence of recur­
rence in 6. The authors noted an overall 
recurrence rate of approximately 25%, and 
eight patients died as a result of their 
malignancy.19
The difference in prognosis between 
squamous cell carcinomas of the skin of the 
pinna and squamous cell carcinomas on 
other parts of the skin can be explained in 
three possible ways: (a) through neglect both 
by patients, who do not seek medical atten­
tion, and by physicians, who do not treat 
these lesions adequately, the prognosis is 
worsened; (b) squamous cell carcinomas 
arising from the skin of the pinna are bio­
logically different from those occurring on
the skin elsewhere; and (c) the unique 
anatomy of the pinna, with its lack of 
adipose tissue or its lymphatic drainage, or 
both, lends itself to the early dissemination 
or inadequate treatment of neoplastic lesions, 
or to both of these eventualities.
At one time—20 to 30 years ago— most 
authors accepted the first hypothesis and 
certainly at that time physicians saw larger 
lesions (diameter, > 4 cm), some of which 
had cervical or generalized metastases, or 
both, at the time of diagnosis. However, in 
the present series, such was not the case. Of 
the 52 cases, in only 2 was the lesion more 
than 4 cm greatest diameter at the time of 
diagnosis. In fact, 31 of 52 (59.6%) lesions 
were less than 2 cm in diameter, and there 
was no evidence of lymph-node or distant 
metastases when treatment was started.
Even so, there were 10 cases (19.2%) in 
which the disease was not controlled. In 
five cases, the lesion had been present for 
less than 1 year at the time of initial treat­
ment. Of particular interest is case 8 (Table 
II); treatment, which consisted of electro­
desiccation and curettage, was initiated only 
3 months after the lesion had been first ob­
served, yet the lesion recurred and meta­
stasized widely within 6 months of treat­
ment. It appears that other factors in addi­
tion to neglect must have brought about this 
poor result.
The mode of initial treatment seemed to 
have little bearing on the results of treat­
ment in the present series. The data do not 
allow one to draw conclusions as to the re­
lative efficacy of various forms of treatment. 
Of the four patients who died as a direct re­
sult of their disease, two had initially been 
treated with electrodesiccation and curet­
tage, one had been treated surgically and 
one had been treated with radiotherapy. 
Probably because of their advanced age, 
many of the patients, including five in whom 
the disease was not controlled, died of un­
related causes.
A brief comment should be made con­
cerning the paucity of women in this series. 
Presumably the explanation is the protection 
that longer hair in women affords the pinna 
from the effect of actinic rays. Perhaps, with 
longer hair having become more fashionable 
in men, this cancer will become less com­
mon.
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Thanks are due to the office staff of the Ottawa Civic Hospital division, Ottawa clinic, Ontario Cancer Foundation, for their efforts, and to Dr. R. Jackson, without whose enthusiasm and guidance this study would not have been possible.
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PERITONEAL LAVAGE IN 
DIAGNOSIS OF ACUTE ABDOMEN
The diagnosis o f the acute abdomen may be 
difficult in the presence of severe, multiple 
injuries or poor patient cooperation. Exami­
nation of the peritoneal fluid is then useful. 
Paracentesis does not always yield fluid, but 
peritoneal lavage does.
C. Evans and his colleagues (Br J Surg 
62: 119, 1975) used peritoneal lavage in 47 
selected adult patients. Routine investigations 
had been unhelpful. The technique was as fol- 
lowsj Diazepam (10 mg) was injected intra­
venously and lidocaine (2%) was infiltrated 
into the abdominal wall. A dialysis catheter 
was introduced into the peritoneal cavity 
(usually below the umbilicus, in the midline) 
and 1 l of saline or other fluid was run in 
over 5 to 10 minutes; after a further 10 min­
utes it was drained. Aliquots were tested for 
bacteriologic and biochemical abnormalities. 
Fluid was normal if it was sterile and con­
tained less than 0.1 x 1012 erythrocytes per litre 
and less than 100 Somogyi units of amylase per 
decilitre. Peritoneal lavage confirmed the 
clinical diagnosis in 34 of the 47 patients; in 
11 it was of positive value, correcting an er­
roneous diagnosis, and in 2 the results were 
misleading. Lavage can only be used for de­
termining the presence or absence of intra- 
peritoneal bleeding or inflammation, not the 
cause itself.
Peritoneal lavage was used for diagnostic 
purposes in a large series of patients with mul­
tiple trauma by W. Gill and colleagues (Br J 
Surg 62: 121, 1975). Bloodstained fluid was 
an indication for laparotomy; 299 of 671 pa­
tients examined were in this category. In 89% 
of the 299, surgically significant lesions were 
found and in 3% the results o f laparotomy 
were negative. Considering the whole series of 
671 patients, false-positive results were re­
ported in 0.11% and false-negative results in 
0.03%. These authors rely on peritoneal lavage 
in the initial evaluation of the abdomen in 
cases of blunt trauma and have had no cause 
for regret.
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an emerging problem
• j
“Bacteroides species are often over- “Our experience with this series of seriousl' 
looked as a cause of serious infec- ill patients provides clinical confirmation t  
tion both by clinicians and micro- complement recent in vitro evidence tha 
biologists. They are most commonly clindamycin is the antibiotic of choice ftv 
associated with intra-abdominal use in bacteroides infections. Not only ; 
and pelvic sepsis following gastro- the response in 17 of the 18 patients favo 
intestinal surgery.” able, but in several it was dramatic.” ,v
Tracy, O., et al. (29 Jan.’72). Haldane, E. V. and van Rooyen, C.E. (1972).
Brit. med.J.,p. 280. C.M.A.J.,p. 1177. 4 .
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bacteroides infection
oaiadnc
PDosunate S.S.
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ichieves prompt and high peak 
ierum levels of active clindamycin
^ well tolerated locally and sys- 
lically following I.M. injection 
I.V. infusion
prescribing information on page 286
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DIAGNOSIS OF TORSION OF 
TESTICLE BY ULTRASOUND
Because delayed or missed diagnosis of torsion 
of the testicle may result in necrosis, accurate 
diagnosis is important. The diagnosis may be 
obvious but, especially when epididymitis or 
torsion of the appendix testis is suspect, it may 
be difficult. A diagnostic technique based on 
ultrasound may then be useful.
On the basis that the distinguishing feature 
of torsion of the testicle is loss of blood flow, 
B. J. Levy (J Urol 113: 63, 1975) used the 
Doppler ultrasonic stethoscope to evaluate 
blood flow and thus diagnostic accuracy. With 
this instrument the intensity of the sound is 
proportional to the blood flow. The technique 
is this: The testicle is auscultated systematic­
ally, starting behind the testicle directly over ' 
the testicular artery as it enters the testicle. Thej  
normal side is the patient’s own control. Ve 
Doppler stethoscope was used in seven pati 
in whom testicular torsion could not be 
eluded. In each of the three patients with tor-' 
sion subsequently proven surgically, the ultra­
sonic stethoscope gave a correct preoperative 
diagnosis. In the two who had proven epi­
didymitis blood flow was greater on the af­
fected than on the healthy side, and in the two 
patients with proven torsion of the appendix 
testis blood flow was similar on both sides.
A surface ultrasonic probe connected to 
either a rate meter or an earphone way used 
by J. F. Pedersen, H. H. Holm and T. Hold 
(J Urol 113: 66, 1975). These authors used 
the Doppler principle in 4 adults and 1 new­
born with suspected torsion of the testicle, 10 
adults with unilateral epididymitis and 30 con­
trol patients without intrascrotal disease. In 
those with acute torsion no sounds emanated 
from the affected testicle; in those with epi­
didymitis the sounds were increased on the 
affected side; and in the controls the sounds 
were equal on both sides.
The diagnostic technique is simple and ac­
curate. It might be useful in other clinical dis­
orders as well, such as arterial embolism and 
thrombosis, and venous thrombosis.
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HISTORY OF M E D IC IN E
INFLUENCE OF THE EDINBURGH MEDICAL SCHOOL 
ON THE EARLY DEVELOPMENT OF McGILL UNIVERSITY*
MAURICE EWING, FRACSt
It would be surprising if an Edinburgh 
medical graduate, walking up to the entrance 
of the Royal Victoria Hospital, Montreal, 
for the first time, were not immediately re­
minded of home. Here is the Royal Infir­
mary, Edinburgh, all over again—the same 
proportions, the crow-step gables and the 
same grey enduring stone. Even the turrets 
are so similar from without that they must 
surely conceal within the domestic plumbing 
so well known to all who have explored the 
intimate recesses of the buildings of Lauris- 
ton Place. Needless to say, none of the long, 
open wards of Florence Nightingale’s day 
still serve their original purpose; a discreet 
glimpse through the ground floor windows 
of the east wing, sadly reveals, instead of the 
familiar orderly row of iron bedsteads with 
red blankets and well-worn sheets, tucked 
in with military precision, only dreary stacks 
of hospital records. The top floor of what 
used to be the old medical wing has, how­
ever, been cleverly converted into a warren 
of laboratories, which serve the department 
of surgery; and here (and this is a familiar 
story) work is done of an excellence that 
matches, in no way, the cramped and shabby 
environment.
Even if the resemblance between the 
Royal Victoria Hospital and the Royal Infir­
mary is fortuitous, it is no accident that the 
Edinburgh medical school has had an im­
portant influence, not only in the establish­
ment of medical teaching at McGill Uni­
versity but also in shaping the development 
of the entire University during the first 25 
years of its existence.
* * *
^Presented to the faculty of medicine, University 
of Edinburgh, Edinburgh, Scotland, December 
1974.
tJames Stewart professor, University of Mel­
bourne, Melbourne, Australia.
Reprint requests to: Dr. M. Ewing, Department of 
Surgery, University of Melbourne, Royal Mel­
bourne Hospital, Melbourne, Victoria 3050, Aus­
tralia.
The story of the early years of McGill 
University is fascinating, and it is not sur­
prising that this period should have been 
assiduously examined and faithfully recorded 
by many historians and archivists, both pro­
fessional and amateur. In this respect, no 
one was more diligent and more produc­
tive than Maude Abbott. She was for many 
years curator of the Pathological Museum at 
McGill, where she prepared an exhaustive 
dossier of cardiac anomalies— a contribution 
that not only established her personal re­
putation in the field of cardiology but also 
provided a valuable starting point for those 
who later became committed to the surgical 
correction of congenital heart disease. Her 
industry and enthusiasm in recording the 
early days of the teaching of medicine in 
Montreal have assured her of an important 
place among the medical historians of North 
America.
When I arrived in Montreal, early in 
1974, to spend part of my sabbatical at 
McGill University, my host, Dr. Lloyd 
MacLean, being aware of my antecedents, 
not surprisingly mentioned the close links 
joining the University of Edinburgh with 
McGill University. In view of my plan to 
spend the second leg of my journey in Edin­
burgh, it seemed proper that I should ex­
plore this interesting historical association.
Early 19th Century and Develop­
ment of Medicine in Montreal
At the beginning of the 19th century, the 
right to practise medicine in Lower Canada 
(now the province of Quebec) depended on 
the granting of a licence issued by the gov­
ernor, on the recommendation of a district 
board of examiners (of which there was one 
in Montreal) composed of a group of doctors 
of known integrity. Provision of an adequate 
number of well-qualified doctors to meet the 
needs of a rapidly expanding community was 
obviously a matter of some concern. It was, 
however, inevitable that, as the province grew 
in size and in importance, possession of a
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university degree should become a prere­
quisite for licensure. For this reason, most of 
the doctors who were admitted to the re­
gister were migrants, in possession of a de­
gree from one of the British or, less often, 
continental, medical schools. Although a 
young Canadian who wished to shape a 
career in medicine could complete part of 
his apprenticeship in his own country, he 
was at some stage required to go overseas in 
order to obtain a university degree. This 
must have been both a demanding and an 
expensive undertaking. The crossing of the 
Atlantic, even in summer, could be hazar­
dous. None the less many of these young 
men found their way to Europe and more 
particularly to Edinburgh, which appeared 
to have an almost unlimited ability to cater 
to the needs of the large numbers of students 
who came not only from other parts of Scot­
land and from the rest of the United King­
dom, but also from the Caribbean, from In­
dia and from North America. „
During the war years, between 1812 and 
1814, the numbers of migrants diminished, 
but the numbers arriving in Canada in­
creased sharply thereafter, when there was 
a fresh exodus of emigrants from the old 
country. Needless to say, the move across 
the Atlantic was not easy, certainly for those 
with few material assets, and this was true 
of most. Often, having arrived in Montreal 
at the start of the Canadian winter and 
physically exhausted by the privations of the 
journey, they found themselves at the mercy 
of a predominantly French society at a time 
when outdoor work was out of the question, 
and when there was little or no suitable 
indoor employment. The newcomers suf­
fered cruelly from inanition and disease. The 
only hospitals available were those run by 
the Roman Catholic Church and, in the face 
of spiralling numbers, it was evident that 
l’Hotel-Dieu, which was the first hospital 
to be established in Montreal, was unable to 
give room to all those presenting. The prob­
lem was most acute for the English-speak­
ing, predominantly Protestant community. 
When, at last, the privations of the new­
comers were recognized, it was this group 
that set up, in 1816, the Female Benevolent 
Society “for the distribution of charity and 
the establishment of a school where the 
children of the poor could be taught that the 
fear of the Lord is the beginning of wisdom”.
As part of a program of charity, the society 
rented a “house or refuge” in the suburb of 
Recollet, just to the south of the old city. 
As a result of the exertions of the deputy 
commissioner general, members of the 
society obtained some condemned barracks 
clothing and with such slender resources 
they were able to accommodate four patients 
in the care of Dr. T. P. Blackwood, a retired 
army surgeon, who gave his services gratuit­
ously.
The scheme, set up as a pilot project, was 
judged to be an immediate success. Plans 
for a more realistic expansion of the hospital 
services were then prepared and put before 
the government of Lower Canada and the 
people. In 1819 a new house was rented, 
this time within the city itself (on Craig 
Street); its greatly expanded facilities al­
lowed the accommodation of 24 patients in 
three wards. This house was named the 
Montreal General Hospital and such was its 
success that the building of the central block 
of a new hospital was completed only a year 
later. This was the genesis of a great teach­
ing hospital with an impressive record in 
scholarship and in patient care.
The first medical officers of the Montreal 
General Hospital were a group of five and 
their names— Robertson, Caldwell, Stephen­
son, Holmes and Loedel—are written large 
in the annals of McGill University.
When these men had first begun to re­
cruit interest in the establishment of a new 
hospital they already had in mind the urgent 
need to make provision for the training of 
medical students. During their long associa­
tion with the Montreal General Hospital and 
with McGill University, the members of this 
group never set this purpose aside, although 
they ran into serious opposition on that 
account. In fact, when the new hospital 
building had only just been completed, they 
made the bold decision to set up what they 
proposed to call the Montreal Medical In­
stitution; and with this in mind they peti­
tioned the Governor General, the Earl of 
Dalhousie. They pointed out the inadequacy 
of medical skill in Lower Canada, the de­
mands made by students for an opportunity 
to study medicine and the existence of good 
facilities for clinical teaching at the new hos­
pital. At the same time, they petitioned the 
Governor General to remodel the board of 
examiners of the district of Montreal so
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that it would consist of the medical officers 
of the proposed new Montreal Medical In- 
sitution. This was an astute move which was 
certain to give them authority in realizing 
their educational ambitions.
Dalhousie promptly accepted both of 
these requests. The institution became active 
without delay, opened rooms in St. James 
Street and advertised, in the daily press, 
a comprehensive course of lectures, which 
they immediately implemented. A library 
was added in 1824. Although the number 
of students attending in the early years was 
not large and although there was no hint of 
financial reward, it is clear that all of 
them continued to honour their declared 
purpose so assiduously that the original 
momentum of the enterprise was sustained 
and its ultimate success ensured.
James McGill
One of the leading citizens of Montreal 
of this era, James McGill died in 1813; the 
provisions of his will had an important in­
fluence on the progress of post-secondary 
education in that city.
James McGill had been born on Oct. 6, 
1745 in Glasgow, Scotland, where his father 
plied his trade as a blacksmith. Old McGill 
must have had some ambition for scholar­
ship; he entered the University of Glasgow 
at the age of 12 but left soon after, not sur­
prisingly without a degree. Believing that he 
could discover for his family a life of greater 
opportunity in North America, he came 
with his two sons and eventually settled in 
Montreal. Being a Scot by birth and a 
Jacobite by inclination (evidently the sym­
pathy of the family was with Prince Charles 
and at least one member fought at Culloden), 
he found himself on good terms with the 
French businessmen and through this asso­
ciation James, his son, became a fur trader.
Having served an apprenticeship in the 
rigours of trapping on foot and by canoe, 
young James graduated to a more secure and 
more comfortable existence as a middleman 
exporting the pelts overseas. He became a 
citizen of consequence and a member of the 
executive council of the province, and, dur­
ing the alarms of 1812, was appointed 
colonel in charge of the city militia, and 
responsible for the defence of Montreal 
against the Americans. He came to own a 
house of distinction at the end of Place
Jacques Cartier in the old city, a historic 
home that unhappily no longer stands. But 
more important was his acquisition, in 1798, 
of a parcel of land of about 46 acres on the 
north side of the city. It was partly cultivated 
and its upper boundary came close to the 
lower slopes of Mont Roval. A small stream 
that crossed the east boundary just north 
of what .is now the main east entrance to 
McGill University was joined by a second 
and then described a wide curve through 
the property. Little wonder that McGill 
called the property Burnside, a name that 
is still commemorated on the sign of an ad­
joining city street. It was already a place of 
some historical importance, for it marked 
the site of an Indian settlement where 
Jacques Cartier, the discoverer of the St. 
Lawrence, first parleyed with the Hochelaga 
Indians.
McGill was buried in a city cemetery, but 
later his remains were brought to the uni­
versity and reinterred, appropriately, in the 
middle of the campus.
Origins of McGill University
In his will, McGill had provided for the 
establishment of a university or college for 
the advance of learning in Lower Canada. 
The value of the land (on which there was 
also a house or cottage) was £5000, but to 
this McGill had added another £10 000 in 
cash. Among the clauses in his will was that 
requiring one college to be named and per­
petually be known and distinguished by the 
appellation “McGill College”.
Also he directed wisely— as it soon be­
came evident— that the purpose of his bene­
faction should be achieved within 10 years 
of his death (i.e. by 1823); it would other­
wise revert, in toto, to his heir in law or to 
his successors. The estate, meantime, was to 
be made over to the “Royal Institution for 
the Advancement of Learning”. Although 
the creation of this body had been contem­
plated by those in government in 1801, 
there was more than a suggestion that this 
was a noncommittal notice of intent aimed 
mainly at placating public opinion. Action 
in relation to its implementation was pre­
cipitated by the need to safeguard the Mc­
Gill benefaction and it was, at long last, con­
stituted in 1819.
Another 2 years were spent in seeking 
the royal charter from King George III.
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This was finally granted in 1821 by King 
George IV. Time was running out for the 
trustees and it was apparent that prompt 
action would be necessary if the conditions 
of the benefaction were to be honoured.
McGill had (again very wisely) required 
the appointment of a competent number of 
professors and teachers to render such an 
establishment effective and beneficial for 
the purpose indicated. Sadly, the institution 
had no money, but, in a hurried move to 
save the day, a series of nominal appoint­
ments was made, of which one of the first 
was that of a professor of medicine. He was 
Thomas Fargues, a Canadian and, ap­
propriately, a graduate of the University of 
Edinburgh, having submitted in 1811, for 
the degree of MD, a thesis on chorea. He 
did not not even live in Montreal, but in the 
city of Quebec. Here he enjoyed, in his 
profession, a position of some consequence 
and one suspects that the propriety of his 
shadow appointment to the chair of med­
icine at McGill must have caused him some 
embarrassment. It is also highly likely that 
the trustees recognized the weakness of their 
case at a time when they still had a legal 
battle on their hands, and that they were 
anxious to establish their claim on a more 
secure basis.
M cG ill  University and the
M edical School
In casting around for ways of gaining 
legal and academic respectability, the trus­
tees of the Royal Institution for the Advance­
ment of Learning were immediately attracted 
by the claims of the Montreal Medical Insti­
tution, which had been going ahead quietly 
with its declared purpose. There was no 
question of the soundness of the credentials 
of the group, for the University of Edinburgh 
had already agreed to accept, as condition 
for the admission of a candidate to the degree 
of medicine, a class ticket from the institu­
tion, although, to be sure, the rate of ex­
change was in favour of the University of 
Edinburgh on a two to one basis. With this 
in mind, the members of the Montreal Med­
ical Institution were invited to the first meet­
ing of what was to become the Burnside Uni­
versity of McGill College. It was held in 
Burnside Cottage in June 1829, when the 
important decision was made to “engraft” 
the Montreal Medical Institution on to the
university as its medical faculty. Perhaps 
the trustees were urged on by the medical 
profession and by their friends, and no doubt 
their action was in some degree conditioned 
by the urgency of the situation. It is, how­
ever, unthinkable that the final judgment 
was not made on the basis of acknowledged 
academic excellence. It must therefore have 
been a source of immense satisfaction for 
the administrators of the new university 
that, on the day of the inauguration, the 
University of Edinburgh promptly amended 
the prevailing rate of exchange and agreed 
to accept, for its degree requirements, a class 
ticket from McGill as being of precisely the 
same value as one from its own medical 
school.
Only one chair was created at the uni­
versity, that in medicine; appointed to it was 
William Robertson, a distinguished and re­
spected senior member of the profession.
Loedel stood down from the faculty soon 
thereafter, but the other four—Robertson, 
Caldwell, Stephenson and Holmes—conti­
nued loyally and effectively to direct medical 
education, both in the Montreal General 
Hospital and in the university. They did
Fig. 1.—William Robertson.
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more than that, for they can properly claim 
not only to have established a medical school 
but also to have initiated and sustained Mc­
Gill in the first 25 years of its history, during 
which time medicine was its one and only 
faculty. Further, they appear to have 
achieved this noble purpose without any 
hint of domestic dissension and without any 
hint of professional or of community con­
flict.
William Robertson (Fig. 1)
Robertson, in terms of experience, was 
the senior member of the group. He was 
born in Kindrochet, Perthshire, Scotland in 
1784 of a well-known highland family. Of 
his education he is reported to have said 
that he “went to school young, under the 
tuition of a country dominie and got on as 
well as highland laddies usually do”. At the 
age of 13 he became an ensign of a highland 
regiment, but he still graduated in medicine 
at the University of Edinburgh before he was 
21. He joined the army as an assistant sur­
geon. He served in the war of 1812 and 
was present at the battle of Queenston 
Heights and also at the storming of Fort
Fig. 2.—William Caldwell.
Niagara. In 1815, at the age of 29, he re­
signed from the army on half pay and set­
tled in Montreal, where he became one of 
its leading practitioners.
William Caldwell (Fig. 2)
William Caldwell, like Robertson, began 
his medical career in the army. He, too, was 
a Scot, born in Ayrshire in 1782. He studied 
medicine in Edinburgh between 1801 and 
1803, but for some reason, which is obscure, 
he received his degree by attestation from 
Marischal College in Aberdeen. He arrived 
in Montreal in 1819. Although he contribu­
ted to the care of the sick in the city of 
Montreal, his contribution to the develop­
ment of the Montreal General Hospital and 
of the McGill University medical school is 
best remembered by an exciting duel at 
Windmill Point on File Perrot on the morn­
ing of Sunday, Apr. 11, 1819. The original 
petition to the government of Lower Can­
ada seeking the development of a new hos­
pital had been blocked by O’Sullivan, an 
Irish-born attorney at law, who challenged 
it on the ground that the situation could be 
solved more promptly, more effectively and 
more economically by simply enlarging 
l’Hotel-Dieu. This seemed to most moder­
ates to be a reasonable suggestion. Unfor­
tunately, he went on to contrast the service 
of the nuns of that institution with the “mer­
cenary hirelings” who would presumably be 
appointed to the staff of the proposed new 
hospital. This was a thoughtless remark that 
immediately upset the promoters of the new 
hospital, prominent among whom were the 
doctors.
The dispute was debated in the press and 
matters went from bad to worse; many harsh 
words were spoken on both sides. Then 
O’Sullivan’s personal courage was called into 
question with the inevitable consequence. 
The pistol duel was fought with exceptional 
tenacity that seems to have been no surprise 
to those who knew the temperament of the 
two contestants. It was only after the dis­
charge of five exchanges that honour was 
deemed to have been done. By now, Cald­
well was wounded in the arm and “the bone 
much shattered”, and O’Sullivan was 
wounded in the chest; and when we recall 
that they were were firing 1-oz bullets, it is 
surprising that they both survived.
After the duel, the original petition to the
292 THE CANADIAN JOURNAL OF SURGERY Vol. 18
government lapsed, but the development of 
the hospital was already assured by en­
thusiastic public support. Caldwell had 
fought his duel in defence of an important 
principle in medical education, and when his 
antagonist blocked the proposal for the 
creation of a new hospital, he challenged it 
most vigorously on the score that its prom­
oters planned to make it a place for the “per­
fection of medical science”, an objective that 
implied, as a prime consideration, the ad­
mission of medical students. O’Sullivan 
is reported (in the Hansard of that day) 
to have said in debate that a hospital con­
tributed to that perfection, because no doubt 
it afforded the best opportunities to make 
experiments— and one of the consequences 
of the perfection of medical science would 
be to render the hospital totally insufficient 
for the public wants. Since then, many 
others have resisted the legitimate develop­
ment of teaching hospitals using precisely 
the same argument; namely, the role of a 
hospital in the training of young doctors 
cannot be reconciled with its primary func­
tion in patient care. Happily, this view did 
not prevail, and it must have been for Cald­
well a matter of immense satisfaction that 
the teaching of students was, from the very 
beginning, a primary aim of the Montreal 
General Hospital. Its purpose was quite 
clearly defined: it was “for the care of the 
sick and the advancement of medical knowl­
edge through teaching and research”.
O’Sullivan became chief justice of the 
court of the Queen’s Bench in Montreal. 
Caldwell became one of the staff members 
of the faculty of medicine. He died of gan­
grene of the lung in the winter of 1832/33, 
only a few months before the medical school 
capped its first graduate, William Logie, a 
man evidently of Scottish descent.
John Stephenson (Fig. 3)
Stephenson was a born leader. It was he 
who prepared the proposal for the creation 
of the Montreal Medical Institution. He be­
came its first secretary and it was appropri­
ate that he delivered the first lectures on 
anatomy and physiology in October 1822. 
Later, his administrative skill was acknowl­
edged when he was made the first registrar 
of the university. He was born in 1794 in 
St. Paul’s Street, Montreal, the narrow busy 
street that still runs east and west along the
length of the old city. His parents, from a 
Scottish family, were among the first Eng­
lish-speaking settlers in Lower Canada. 
Although he was never a Catholic, he 
received much of his early education from 
the priests of the College de Montreal; 
later he accepted appointment as a physician 
to the order of St. Sulpice. He was then ap­
prenticed on payment of a fee of £50 to 
Robertson, the first professor of medicine, 
who gave him an excellent report when he 
went on to study in Edinburgh and later 
in Paris.
In Paris he worked assiduously for 6 
months under the direction of Dr. Roux, 
one of the leading surgeons of his time. It 
was when Stephenson was just about to re­
turn to Edinburgh to receive his degree that 
Roux, in an unsolicited consultation (it seems 
that it was the first time Stephenson had 
spoken to his teacher), discovered that his 
young pupil had a median cleft in his soft 
palate. Stephenson, beset with grave feed­
ing difficulties in infancy, had been left 
with a gross speech defect, which, on the 
basis of a rather casual examination by the 
family doctor early in life, had been ascribed
Fig. 3.—John Stephenson.
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to infection; there was more than a sugges­
tion that it was syphilitic in origin, as his 
brother was similarly affected. Stephenson 
was anxious to explore the possibility of 
operative repair of the deficiency and Roux 
was equally receptive to the idea. Stephen­
son’s return to Edinburgh was deferred and 
the operation was carried out a few days 
later. It was completed in 1 hour and with­
out anesthesia. It was conducted in some 
secrecy for it was the first time that Roux 
had attempted the operation and he was 
somewhat fearful of the outcome. However, 
it was a great success and Stephenson was 
able to give a personal account of it to the 
members of the Royal Institution of Paris 
on the 13 th postoperative day, before leav­
ing the next day for the long trip back to 
Scotland. Not surprisingly when, in 1820, 
the name of Jonnes Stephenson appeared 
in the list of successful candidates for the 
degree of MD in Edinburgh, the title of his 
thesis was “De Velosynthesis” . (The fascin­
ating story of this important landmark in the 
evolution of the operation for cleft palate 
has been delightfully told by Wallace.1- 2) 
Stephenson returned to Montreal where he
Fig. 4.—Andrew Holmes.
built up a large surgical practice. He was 
a man of great scholarship and he was much 
influenced by recollection of the kind of 
educational experience he had enjoyed when 
he studied in Europe. His nephew was to 
say later:
“He was very much aware of the absence of 
that literary and artistic culture and society 
which had become almost necessary to him 
and the absolute dearth then existing of educa­
tional establishments for the English speaking 
portion of the community, that he resolved 
to do, what in him lay, to serve those for his 
countrymen and devoted himself for the first 
year of his return, to procure them that ad­
vantage.”
Andrew Holmes (Fig. 4)
Holmes, the fourth member of the group, 
was undoubtedly the best scholar of them 
all. In the list of graduates in medicine of 
the University of Edinburgh for the degree 
of MD the entry reads as follows: “Holmes, 
Andreas F. Americanus de Tetano”. His 
middle name was Fernando and this no 
doubt records the accident of his birth in 
Cadiz in 1797. His parents had been taken 
there as prisoners, when captured by a 
French frigate while sailing to Canada on a 
British ship. Four years elapsed before the 
family was allowed to continue its journey 
to North America, settling first in Quebec 
and later in Montreal. Here he received, at 
the school of Dr. Alexander Skakel, the 
formal training in the classics that was then 
a prerequisite for a career in medicine.
Dr. Alexander Skakel had been born in 
Fochabers in Banffshire in 1776, graduating 
as an MA in Aberdeen in 1797. He started 
the Montreal Classical and Mathematical 
School, which came to enjoy a notable re­
putation. Perhaps his career is relevant to 
the development of McGill University. He 
emigrated from Scotland with John Strachan, 
a Presbyterian who later joined the Angli­
can Church and became the bishop of To­
ronto. Both Strachan and Skakel became 
close personal friends of McGill and are 
believed to have played an important part in 
encouraging him to leave his estate for the 
establishment of a university. Skakel later 
became the first chairman of the Montreal 
General Hospital. His scholarship was ack­
nowledge by the bestowal of an honorary 
LL B of the University of Aberdeen, and 
his success as a dominie was evident from
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the size of his estate ( f 15 000), all of which 
he willed to the Montreal General Hospital.
But to return to Andrew Holmes. At the 
age of 14 he was articled to Dr. David Ar- 
noldi, perhaps the most prominent man in 
his profession in Lower Canada. It was ap­
parent, however, that Holmes had ambitions 
to progress further in his profession and he 
went overseas to join Stephenson, with 
whom he then studied in Edinburgh, in 
Dublin and in Paris.
While in Edinburgh, he made a notable 
collection of the local flora and because of 
his interest, not only in botany, but also in 
gemmology and geology, he was, in 1818, 
made a member of the Edinburgh Physical 
Society. In July 1819, on the eve of his 
departure, he was afforded the rare privilege 
of being elevated to extraordinary member­
ship in the society.
On his return from overseas, Holmes 
made moves to incorporate the Natural His­
tory Society in Montreal and made a com­
prehensive collection of 500 plants illustra­
ting the flora of Montreal. Between 1822 
and 1838 he collected about 4000 geological 
specimens, all of which he made over to 
the Redpath Museum at McGill University 
Among them was what he believed to be a 
new mineral, a brittle mica consisting large­
ly of magnesia, which he had discovered 
in Amity in New York state. This was sub­
mitted to Professor Thompson in Glasgow 
who suggested that it should be called 
holmesite. Later, however, it became evi­
dent that Holmes had been beaten to the 
post by a Swiss geologist who had reported 
his discovery only a few weeks earlier. Al­
though dispersed widely in the Redpath 
Museum, Holmes’ collection still forms a 
valuable reference to the geological con­
figuration of the city of Montreal, because 
access to most of Montreal’s geological 
structure is now denied by building develop­
ment.
He taught chemistry in the university 
until 1843 when, on the death of Robertson, 
he was appointed to the chair in medicine. 
Although Holmes became the first dean of 
the faculty in 1854 and although he played 
a prominent part in the development of the 
Lying-in Hospital, he never seems to have 
become involved in the rough and tumble 
of medical politics, but continued rather to 
foster his scholastic pursuits.
Holmes made several modest contribu­
tions to the medical literature of his time. 
Early in his career he reported a case of 
vagitus uterinus.3 He lived through the 
agonies of the cholera epidemic that struck 
Montreal in 1833 and literally decimated 
its population of 30 000; on June 19 of that 
year there were no fewer than 149 burials. 
Later, he answered a series of questions di­
rected to him by a Dr. Patel of Philadelphia 
and the correspondence between the two was 
published in the form of a paper in the 
British American Journal. This incorporated, 
in Holmes’ contribution, an excellent ac­
count of the clinical appearance of a patient 
with cholera. He had tried the intravenous 
use of salt and water in six patients, five of 
whom died. One, who survived for 8 days, 
died from “an oppressed brain”. Of blood­
letting, he had nothing good to say; it was 
evident that he had, under these circum­
stances, the greatest of difficulty in recover­
ing any blood at all.
Holmes was, in every sense, a great 
scholar. MacCallum, who was a student at 
McGill in 1847 and who was later to occupy 
the chair of obstetrics and gynecology, saw 
him as a person with a quiet voice and little 
animation. He was, however, impressed by 
his vigorous and lucid style of which his 
valedictory address to the students at con­
vocation in 1854 is a good example:
“There are two errors to be avoided: an over­
weening preoccupation that we are very wise, 
which leads to dogmatism and quackery; and 
want of self reliance, which leads to inefficien­
cy. In our approaches to one or other of these 
errors, a great deal will depend on tempera­
ment; both of them, however, lead to one re­
sult, a system of routine—the one asserting 
the supremacy of its knowledge, will not con­
descend to alter; the other, fearful of untried 
consequences, prefers the beaten track. Routine 
is not the part of a scientific physician whose 
decisions and directions should always have 
a basis of reason.”
This was the good advice he gave to his 
students on another occasion (a message 
that he passed on almost 125 years ago):
“If I have succeeded in impressing you with 
the propriety of not lagging behind any ad­
vance which your profession is continually 
making, I shall point out to you one easy 
means by which you may always know what 
is going on in the world of medicine. It is to
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take one or more of the periodicals which are 
now so numerous and so low priced that no- 
one is justified in remaining in ignorance with 
so easy a method of acquiring information. 
Many of you no doubt will fix your residences 
in country parts where you may have little 
opportunity of communion with other prac­
titioners and you will therefore be very likely 
to become ‘rusty’ in regard even to the 
knowledge which you now have and much 
more in regard to that which is being de­
veloped every day. The best way of preventing 
this is to take a periodical whose pages contain 
a condensation of the mass of new matter 
which is monthly and weekly poured upon 
the profession. The practice of reading such 
work may have another benefit; it may stir 
you up to communicate the results of your 
own experience and many valuable facts and 
observations may thus be saved and rendered 
useful; and hereby you will be fulfilling, in 
some measure, the duty which I passed upon 
you namely, that of becoming a credit to the 
University.”
It is appropriate that the Holmes medal, 
which was cast in his honour in 1864, is now 
given each year to the student who gains 
most marks in all subjects of the curriculum.
Holmes died suddenly at his desk while 
preparing papers for a faculty meeting. The 
obituary notice in the local medical journal 
curiously included, in addition to the cus­
tomary eulogies, the full autopsy report. Al­
though decomposition had already set in, 
we are told that all of the members of the 
faculty of medicine faithfully attended the 
autopsy, no doubt as a somewhat macabre 
expression of interest and sympathy—yet a 
gesture that today would require an un­
reasonable degree of academic solidarity.
This, then, was the band of relatively 
young men who staffed the new Montreal 
General Hospital, who recognized the need 
to make provision, in it, for the instruction 
of students of medicine, who formally estab­
lished the Montreal Medical Institution, 
who were engrafted on to McGill University 
as the faculty of medicine and by whose 
efforts McGill University can properly claim 
to have been initiated and sustained in the 
first quarter century of its existence. It is 
a wonderful story of the birth of a tremen­
dous enterprise from a small beginning. 
Robertson and Caldwell knew of the op­
portunities presenting in the old world, and 
Stephenson and Holmes recognized clearly,
from their own personal experience, the 
difficulties with which young Canadians 
were confronted in shaping a career in 
medicine. But from the way the four set out 
to achieve their purpose, it is evident that 
they were primarily urged on by the high 
rating that they all gave to education and 
to scholarship. It would be satisfying to be­
lieve that their sense of values was deter­
mined, at least in part, by their period of 
stay in Edinburgh. It is certainly true that 
they kept reverting to their common exper­
ience and that they must have valued highly, 
the system of instruction that prevailed in 
the Royal Infirmary of Edinburgh. From 
the very beginning students were to be ad­
mitted freely to the wards for teaching and 
for study and there they “followed the 
methods of Edinburgh, making clinical in­
struction at the bedside an integral part of 
hospital routine and an essential feature of 
the curriculum”.
They were also influenced a good deal 
in their early decisions by the lessons of 
history, because in paragraph 5 of the 
original petition for the creation of a new 
hospital, they noted:
“v. They are further encouraged to attempt 
the founding of a medical seminary when they 
reflect that the Medical School of Edinburgh, 
the basis of which they would adopt for their 
present institution, now justifiably considered 
the first in Europe, is of comparatively recent 
formation, it being little more than one hun­
dred years since medical lectures were first 
delivered in that city and the early history of 
the Royal Infirmary of Edinburgh is not dis­
similar from that of the Montreal General 
Hospital.”
It is certainly true that, from the time 
of the opening of the Royal Infirmary of 
Edinburgh in 1741 or thereabouts, students 
enjoyed the privilege of attending patients in 
the hospital; and it was the urgings of the 
extramural school, the acknowledged short­
comings of the systematic instruction within 
the university, and the existence of a hos­
pital designed to cater for the needs of med­
ical education that finally provoked the 
university to accept the responsibility for the 
formal direction of the clinical subjects in 
the curriculum.
A  C o n tin u in g  R e latio n sh ip
As an index of the continuing interest of
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McGill University in the University of Edin- | 
burgh, the former adopted, in 1842, the 
Sponsio Academica. This was introduced in 
1803 by the University of Edinburgh as the 
declaration of faith and purpose of the stu­
dents graduating in medicine and represented 
a modified version of the Hippocratic oath.
The role of the University of Edinburgh 
in the development of McGill University 
should be for Edinburgh a source of 
satisfaction. It was fitting that this associa­
tion should be commemorated by a plaque 
that was conveyed to Montreal by Professor 
Donald, dean of the faculty, some years ago.
It now occupies a position of honour in the 
foyer outside the office of the dean on the 
sixth floor of the magnificent new McIntyre 
building which houses a considerable part 
of the faculty of medicine. On it is inscribed:
“This tablet has been erected by the University 
of Edinburgh as a symbol of the bond between 
that historic centre of learning and McGill 
University, and in memory of the founders of 
McGill University William Caldwell, A. F. 
Holmes, William Robertson, John Stephenson, 
all of whom received their training at the Uni­
versity of Edinburgh.”
I would also like to believe that this old 
and close association continues to mean 
something to the McGill medical school, as, 
for example, in meeting the challenge thrown 
out by Archibald Hall, another Edinburgh 
graduate, when, in his introductory lecture 
to the class of students in midwifery in 1869, 
he said:
“in subsequent years, when we are gathered 
to our fathers, our young men may point to 
this city, as we do now to Edinburgh and pro­
nounce it, as well from its edifices as from its 
educational establishments, the modern Athens 
of Canada”.
The author gratefully acknowledges the help of 
Dr. E. H. Bensley, department of history of med­
icine, McGill University; the staff of the Osier 
library at McGill University, and Miss Wardill, 
librarian at the Royal College of Surgeons of 
Edinburgh.
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B O O K  R E V I E W S
ACUTE FLUID REPLACEMENT IN THE 
THERAPY OF SHOCK. Edited by Theo­
dore I. Malinin, Robert Zeppa, William R. 
Drucker and Arthur B. Callahan. 307 pp. 
IIIlist. Stratton Intercontinental Medical Book 
Corp., New York; Longman Canada Limited, 
Toronto, 1974. $27.00.
This multiauthored text (38 papers) presents 
the proceedings of a conference sponsored by 
the office of naval research and the department 
of surgery, University of Miami. Most of the 
presentations, which were originally given in 
June 1973, are excellent but a few are irre­
levant. Varied and frequently opposing argu­
ments appear throughout the text, especially on 
appropriate regimens for volume replacement 
and dangers to pulmonary function.
Despite these limitations, the volume is an 
excellent summary of the state of the art with 
particular reference to blood, blood products 
and other volume replacements that are now 
or will in the future be useful in the therapy 
of hypovolemia.
The clinical implications of severe blood loss 
are discussed in a particularly interesting sec­
tion. Surprisingly few controlled clinical stud­
ies are available to support therapeutic regi­
mens but overall the text is practical and will 
be useful to clinician and researcher alike. In 
a calm and organized summary the editors im­
ply that several routes to successful therapy 
are possible, that good patient care need not be 
a research project, and that the framework 
exists for understanding the physiologic de­
rangements of shock particularly those due to 
hypovolemia. Firm and useful recommenda­
tions on therapy are made without controversy. 
Obvious areas for clinical investigation are 
highlighted.
L. D. MacLean
Department of Surgery,
Royal Victoria Hospital,
Montreal, Que.
ADVANCES IN SURGERY. Volume 8. Ed­
ited by R. M. Zollinger. 333 pp. Illust. Year 
Book Medical Publishers, Inc., Chicago, 
1974. $24.50.
The format of volume 8 of this, annual review, 
which originated in 1967, is unchanged. Rec­
ognized authorities in various fields have con­
tributed well-written chapters emphasizing re­
cent advances in surgery.
Nine diverse clinical and physiologic chal­
lenges of specific or widespread surgical in­
terest have been reviewed. Five chapters pre­
sent current concepts of problems encountered 
in all surgical specialties. The first of these 
discusses newer approaches to nutritional prob­
lems, starting with a presentation of techniques
and methods of alimentation (both gastroin­
testinal and parenteral) and outlining the ad­
vantages and complications of each. Common 
nutritional problems in surgical patients and 
the various surgical procedures that alter nu­
trition are considered. The chapter on the effect 
of halogenated anesthetics on liver metabolism 
and immune response is particularly well il­
lustrated. Another section deals well with the 
general principles of radioimmunoassay, speci­
fic assays and their clinical relevance. A chap­
ter on daily problems in the intensive care unit 
is well organized and presented. Practical 
physiology and also specific problems are 
clearly outlined. Finally, a review of the diag­
nosis and treatment of wound failure details 
the process of wound repair and considers 
failure to heal and its surgical complications.
Chapters of more limited interest include an 
expert overview of the role of surgery in 
duodenal ulcer and comparison of the overall 
results of standard surgical procedures and 
their complications. Highly selective vagotomy 
is considered in detail. Indications for hepatic 
resection, techniques and postoperative care 
are reviewed. Pediatric surgery is represented 
by a chapter on the treatment of biliary atre­
sia. Finally, there is a detailed current assess­
ment of the management of malignant mela­
noma.
This book has been well edited. Each chap­
ter is well organized and illustrated, with 
lengthy bibliographies. It is highly recom­
mended reading for all surgical practitioners 
and students.
K. D. Bury
Department of Surgery,
The Wellesley Hospital,
Toronto, Ont.
BONNEY’S GYNAECOLOGICAL SUR­
GERY. 8th ed. John Hawkins and John
Stallworthy. 868 pp. Illust. Bailliere Tindall,
London, 1974. <£11.00. $26.50 (approx.).
Generations of gynecologists are indebted to 
this classic work on the surgery of their spe­
cialty. Its authority and wisdom arise from the 
tremendous personal experience of the late 
Victor Bonney, his meticulous observation of 
the details of operative procedures, and his 
objective appraisal of his results. It provides 
a fund of practical advice for every untoward 
situation and complication. The illustrations 
(the work of the author himself) demonstrate 
clearly every step of the operation described.
Some might question the advisability of at­
tempts to keep up to date established texts that 
have served their purpose in the past. In the 
present instance any doubts in this regard are 
groundless. Since the fifth edition the book 
has been edited by a succession of Bonney’s
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former associates who have been successful in 
incorporating current advances in the art with­
out sacrificing the flavour and outlook of the 
original. The student will find, therefore, am­
ple descriptions of modern methods of inves­
tigating and treating stress incontinence, and 
the techniques of tubal anastomosis and con­
struction of the artificial vagina. Presentation 
of results from various centres in the United 
Kingdom indicate changing trends in prac­
tice—for example, the popularity of vaginal 
hysterectomy combined with vaginal repair in­
stead of the former reliance on the Manchester 
operation to correct relaxation of the vagina 
and pelvic floor. As one would expect, apolo­
gies are offered for including the description 
of subtotal hysterectomy, and an account of 
extraperitoneal cesarean section is deliberately 
omitted.
This book is a superb testimony to the 
achievements and influence of a master of its 
subject and of his disciples.
A. W. A ndison
Ottawa, Ont.
THE CARE OF THE RHEUMATOID
HAND. 3rd ed. Adrian E. Flatt. 296 pp.
Iilust. The C. V. Mosby Company, St. Louis,
1974. $26.00.
There are now six editions of Flatt’s two 
books on the hand. These have become familiar 
to orthopedists. I refer to three editions of 
“The Care of Minor Hand Injuries” and now 
a third edition of “The Care of the Rheuma­
toid Hand”. I did not intentionally link these 
books together but they all commence with a 
rather lengthy discussion on anatomy, with 
many of the now familiar models describing 
Flatt’s own concept of skeletal anatomy and 
“kinesiology”. Like motherhood this is not to 
be challenged—yet, do many of us study it? 
I imagine surgeons hurry through to the “tech­
niques”. As Flatt (like John Masters and 
Arthur Hailey) seems intent on producing 
books every year or so it is not surprising that 
much of this section is copied from edition to 
edition.
A previous reviewer described Flatt’s style 
as “ponderous prose”. This is unjust. This 
book comprises the very best of English style 
and open, well-illustrated American medical 
printing.
In the general section on rheumatology for 
surgeons there are some interesting individual
viewpoints including a play on words, which 
concludes that rheumatoid skin heals normal­
ly whereas the evidence indicates that it may 
heal badly if the patient has been on pro­
tracted cortisone therapy. The section on 
splinting is worth close study. It should be 
noted that dynamic splints alone will not pre­
vent deformity for long. (Rheumatologists in 
particular should be compelled to read this 
book before being granted their Fellowship.)
Sections on the surgical management of all 
the common deformities of the wrist, hand and 
fingers follow. These are exhaustive, detailed 
accounts of the various techniques for rheu­
matoid disease in the hand and are intended 
for the relatively few (in Canada) who have 
interested themselves in this subject. I was a 
little surprised to see continued praise for ex- 
cisional arthroplasty of the elbow. Some of 
the newer prostheses are giving better results, 
certainly more stability.
The continuity of the text suffers from in­
terposition of sections on natural history and 
end-results described in tables of degrees that 
will have appeal to only a few individuals.
Much space is given to the role of prosthetic 
replacement of metacarpophalangeal joints 
versus excisional arthroplasty. The conclusions 
are still unclear and most hand surgeons would 
prefer prosthetic replacement with a Silastic 
insert. Flatt’s own metal prostheses are il­
lustrated but are apparently unobtainable and 
his technique for these joints is not described. 
I was surprised to see no reference to one of 
the principal advantages in the use of meta­
carpophalangeal prostheses —  cosmesis. Pa­
tients are often delighted by the alignment of 
fingers although some movement seems to be 
lost.
Sections on small-joint procedures are dis­
cussed fully and are beyond any real criticism.
This volume is probably already in the pos­
session of every hand surgeon. It should be 
read by all rheumatologists and surgical 
examination candidates as well. It represents 
an authoritative review of a subspecialty. The 
book demonstrates all that is best in a mono­
graph, and the views of others are well pre­
sented.
I shall value my copy, refer to it and await 
its successor.
A. M. W iley
Department of Surgery,
Toronto Western Hospital,
Toronto, Ont.
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Bonney’s Gynaecological Surgery. 8th ed. John 
Hawkins and John Stallworthy. 868 pp. Must. 
Bailliere Tindall, London, 1974. £11.00. $26.40 
(approx.).
La Chimiotherapie des Cancers (Leucemies, He- 
matosarcomes et Tunieurs Solides). 3rd ed.
Georges Mathe and Yvon Kenis. 523 pp. Must. 
Expansion Scientifique Frangaise, Paris, 1975. 
248 F. $60.00 (approx.).
Gynecologic Surgery. Errors, Safeguards, Salvage. 
John W. Ridley. 317 pp. Must. Williams & 
Wilkins Company, Baltimore; Burns & Mac- 
Eachern, Toronto, 1974. $21.45.
Orthopaedic Surgery in Infancy and Childhood.
4th ed. Albert Barnett Ferguson, Jr. 791 pp. 
Must. The Williams & Wilkins Company, Bal­
timore; Burns & MacEachem, Toronto, 1975. 
$53.50.
The Physiology of the Joints. Vol. 3. 2nd ed. I.
A. Kapandji. Translated by L. H. Honore. 251 
pp. Must. Churchill Livingstone, Edinburgh; 
Longman Canada Limited, Toronto, 1974. 
$14.50. Paperbound.
Reviews in Paediatric Urology. Edited by J. Her­
bert Johnston and Willard E. Goodwin. 482 pp. 
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Elsevier Publishing Company, Inc., New York, 
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NOTICES
INTERNATIONAL WORKSHOP ON 
ATHEROSCLEROSIS
An international workshop-conference on athero­
sclerosis, sponsored by the Ontario Heart Founda­
tion, the Canadian Heart Foundation, the Univer­
sity of Western Ontario and the European Athero­
sclerosis Group, will be held at the University of 
Western Ontario from September 1-3, 1975. The 
registration fee is $50.00. For further information 
write to: Miss Evelyn McGloin, Director Profes­
sional Education, Ontario Heart Foundation, 310 
Davenport Rd., Toronto, Ont. M5R 3K2.
INTERNATIONAL SYMPOSIUM ON 
PEDIATRIC OTORHINOLARYNGOLOGY
The Children’s Mercy Hospital of Kansas City, in 
cooperation with the University of Missouri-Kan- 
sas City School of Medicine and the Southwest 
Pediatric Society, will hold an international sym­
posium on pediatric otorhinolaryngology from 
September 11-13, 1975. Members of the guest 
faculty are from Europe, the United States, Can­
ada and Mexico. The registration fee is $150.00 
for physicians, $50.00 for residents. For further 
information write to: Dr. B. Jazbi, Chief of 
Otorhinolaryngology, The Children’s Mercy Hos­
pital, 24th at Gillham Rd., Kansas City, Missouri 
64108.
